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ABSTRACT 
Although it is well known that an increase in sodium intake (Na+) increases BP and is 
involved in the development of salt-sensitive hypertension (SS-HTN), the mechanism 
responsible for this increase in BP is uncertain. Further while low dietary potassium 
(K+) is also associated with the development of SS-HTN it is uncertain to what extent 
dietary potassium (K+) affects Na+-induced increases in BP. The purpose of this study 
was to determine whether Na+-induced increases in BP and target organ changes are 
altered by reductions in K+ intake. Four-month-old male Sprague-Dawley (SO) rats 
were randomly assigned to three dietary intervention groups for six weeks: a normal 
Na+ (0.3%), normal K+ (1.6%) group (CON, n=12), a high Na+ (6%), normal K+ (1.6%) 
group (NK+-HNa+, n=12) and a high Na+ (6%), low K+ (0.01%) group (LK+-HNa+, 
n=12). Tail-cuff BP, body weight, food and water intake were measured weekly. At 
termination, urine parameters, right kidney weight as well as left ventricular 
dimensions and function were measured. Vascular reactivity of the mesenteric and 
renal arteries was also assessed using a wire-myograph. During the diet intervention, 
water intake was significantly higher in the NK+-HNa+ and LK+-HNa+ groups 
compared to the CON group (P<0.0001). Although food intake was significantly lower 
in the NK+-HNa+ and LK+-HNa+ groups compared to the CON group during the first 
week (P=0.03 and P=0.05 respectively), no significant differences in body weight 
were observed between the groups (P>0.05). The urinary Na+/K+ ratio was higher in 
the LK+ HNa+ compared to the CON and NK+ -HNa+ groups (P<0.001). Following the 
6 week dietary intervention, the systolic BP was significantly higher in the NK+-HNa+ 
and the LK+-HNa+ groups compared to the CON group (P=0.05 and P=0.04 
respectively). The diastolic BP was significantly higher in the NK+-HNa+ and LK+-
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HNa+ groups compared to the CON group (P=O.05 and P=O.02, respectively). The 
increase in BP was not different between the NK+-HNa+ and LK+-HNa+ groups 
(P>O.05). In the mesenteric arteries, there was a significant increase in vascular 
responsiveness to phenylephrine in the NK+-HNa+ group compared to the CON group 
(P=O.02). However the vascular responsiveness to phenylephrine in the mesenteric 
arteries was similar between the NK+-HNa+ and LK+-HNa+ groups (P=O.82). No 
significant differences in vascular reactivity were observed in the renal arteries 
between the three groups. No significant differences were observed in the left 
ventricular dimensions and function between the different diet groups (P>O.05). In 
conclusion, 6 weeks of high Na+ intake increases BP, induces greater phenylephrine-
induced contractions in mesenteric arteries but does not affect heart dimensions and 
function. The greater phenylephrine-induced contractions with a high Na+ intake may 
be responsible for the increase in BP. However a reduction in dietary K+ intake does 
not have any effect on the high Na+-induced changes in BP or mesenteric artery 
reactivity. 
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CHAPTER 1 
INTRODUCTION 
1 
Hypertension, or high blood pressure (BP), is a serious clinical and public health 
challenge in both developed and developing countries and South Africa is no 
exception (Bertram et al., 2012). Hypertension is a major risk factor for 
cardiovascular disease including stroke (Connor et al., 2009), congestive heart 
failure (Stewart et aI., 2008), and peripheral vascular disease (Nguyen et aI., 
2013) and is recognized as one of the leading causes of morbidity and mortality 
worldwide (WHO, 2012). According to the WHO, hypertension affects 
approximately 1 billion individuals worldwide and its occurrence is estimated to 
increase by 60% to a total of 1.54 billion individuals by 2025 (WHO, 2013). In 
South Africa, approximately 21 % of the population suffers from hypertension 
which accounts for almost 10 million individuals (Kowalski, 2007). In South Africa, 
hypertension-related mortality was estimated at 9% of all deaths in the year 2000 
(Norman et aI., 2007). Moreover 50% of strokes and 42% of ischaemic heart 
disease were attributed to primary hypertension (Norman et al., 2007), indicating 
the considerable burden of hypertension in South Africa (Bradshaw et al., 2003; 
Norman et aI., 2007). 
Furthermore the burden of hypertension in black South Africans has risen 
substantially in the past couple of decades (Sliwa et al., 2008; Tibazarwa et al., 
2009) and may be explained by the transition from traditional African lifestyles to a 
more westernized lifestyle (Hamer et aI., 2011). Considering the substantial 
burden of hypertension in South Africa, focusing on the fundamental causes and 
understanding the mechanisms that contribute to the development of hypertension 
is important in order to improve management and treatment strategies. 
Although the causes for the development of hypertension have been studied 
widely, the underlying mechanisms are still not well understood. Numerous 
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genetic and environmental factors are believed to contribute to the development of 
hypertension (Carretero and Oparil 2000; Oparil et a/., 2003). 
Although a number of environmental factors are associated with hypertension, 
dietary factors have substantial effects on BP homeostasis (Carretero and Oparil 
2000; Oparil et a/., 2003). In this regard a substantial body of evidence from both 
human (Appel et a/., 2006; Danaei et aI., 2009; Cook et a/., 2007; Cook et a/., 
2009; Umesawa et a/., 2008) and animal studies (Giardina et a/., 2001; Koga et 
a/., 2008; Siegel et a/., 2004; Sofala et a/., 2002; Wu et a/., 2000) suggest that 
high dietary sodium (Na+) intake is an important dietary factor in the development 
of hypertension. 
Furthermore evidence suggests that groups of African descent tend to increase 
BP to a greater degree in response to a Na+ load than other ethnic groups (Gibbs 
et a/., 1999; Luft and Weinberger, 1997) and hence have a higher prevalence of 
"salt-sensitive" hypertension (SS-HTN) (He et a/., 1998; Sowers et a/., 1988; Tiffin 
et a/., 2010; Vollmer et a/., 2001; Weinberger et a/., 1986; Wright et a/., 2003). 
Although Na+ has until recently been considered the most influential dietary factor 
in the development of hypertension, numerous studies have reported that a 
dietary deficit in potassium (K+) also has a critical role in the development of SS-
HTN (Adrogue and Madias, 2007; Cohen and Townsend, 2008; Hedayati et a/., 
2012). Evidence indicates that groups of African descent have a lower dietary K+ 
intake which has been associated with an elevation in BP and a higher risk for SS-
HTN (Houston, 2011; Turban et aI., 2008). 
In this regard, studies suggest that although Na+ and K+ relate to cardiovascular 
outcomes, the ratio of Na+ and K+ (Na+/K+) is believed to be a better determinant 
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of SS-HTN than either Na+ or K+ alone (Perez and Chan, 2014; Sacks et a/., 
2001). 
Despite the evidence that not only increased Na+, but also decreased K+ may 
contribute to the pathogenesis of SS-HTN, public health initiatives to date have 
focused exclusively on Na+ reduction. Moreover, most of the studies on SS-HTN in 
humans have been cross-sectional. Our laboratory has demonstrated in black 
South Africans that Na+ intake (indexed as urinary Na+/K+) is more closely 
associated with central (aortic) than with peripheral (brachial) BP (Redelinghuys et 
a/., 2010) and that associations between urinary Na+/K+ and BP may in part be 
explained by insulin resistance (Millen et a/., 2013), circulating angiotensinogen 
(Michel et a/., 2012) and aldosterone-to-renin ratio (Scott et a/., 2011). However, 
due to the cross-sectional nature of these studies, direct assessments of end-
organ damage and mechanisms of these relationships cannot be drawn. 
Moreover as Na+ supplementation and K+ restriction in humans are ethically 
limited by the extent to which Na+ intake may be increased and K+ intake may be 
decreased, animal studies are required to appropriately assess the impact of 
variations in Na+ and K+ intake on BP. 
Furthermore, the mechanisms responsible for SS-HTN in a high Na+ and a low K+ 
environment are still relatively unknown as very little evidence is available 
regarding SS-HTN in rats with a low K+ diet. In order to have effective treatment 
strategies, a detailed and systematic investigation is needed to further elucidate 
possible mechanisms of SS-HTN. 
In the present dissertation, chapter 2 begins with a literature review that 
summarises the current knowledge and incongruities in the field, which will 
highlight the reasons for conducting the study presented in this thesis. In particular 
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the literature review focuses on the effects of dietary Na+ and K+ intake on BP and 
on consequential target organ damage. Chapter 3 describes the methodology 
employed in the study and in chapter 4 the results obtained are presented. 
Chapter 5 discusses the findings in context to the scientific literature and chapter 6 
concludes and highlights the limitations and clinical implications for this study. 
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CHAPTER 2 
LITERATURE REVIEW 
6 
2.1 Salt-sensitivity 
Hypertension is characterized by a SBP exceeding 140 mm Hg and a DBP greater 
than 90 mm Hg (Vikrant and Tiwari, 2001) and can be classified as either primary 
or secondary hypertension. Primary hypertension accounts for approximately 95% 
of all cases of hypertension (Carretero and Oparil, 2000; Oparil et a/., 2003) and 
will thus be the focus of this literature review. A number of causative factors are 
associated with the development of primary hypertension including insulin 
resistance, obesity, kidney disease, genetics, aging and other lifestyle related 
factors such as lack of physical activity (Lindgarde et al., 1987; Perry et al., 1994; 
Oparil et al., 2003). However the exact mechanisms underlying the development 
of primary hypertension remain unclear (Cutler, 1996; Carretero and Oparil, 2000). 
In addition to these factors, diet also plays an important role in the development of 
primary hypertension. Among dietary factors playing an important role in the 
development of primary hypertension, dietary Na+ intake is considered the single 
most important modifiable contributor towards the development of primary 
hypertension (de Wardener and McGregor; 2002). Nevertheless the extent to 
which BP responds to changes in Na+ intake varies widely among individuals 
(Campese et al., 1994; Siani et al., 2000; Weinberger, 1996). While a high Na+ 
intake raises BP in some individuals, no variation with Na+ (or even a decrease in 
BP) has been observed in some other individuals (de la Sierra et al., 2002). These 
observations suggest that some individuals are salt-sensitive whilst others are 
salt-resistant. However, no standard criteria is currently applied uniformly to 
distinguish between salt-sensitive and salt-resistant individuals (Meneton et al., 
2005). Various criteria have been used to define salt-sensitivity. Weinberger et al 
(1986) defined salt-sensitivity as a 10% increase in mean arterial pressure (MAP) 
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when a high Na+ diet was administered compared with a low Na+ load 
(Weinberger et al., 1986). Using this criterion Weinberger et al (1986) reported 
that approximately 51 % hypertensive individuals and 26% normotensive 
individuals were considered salt-sensitive (Weinberger et a/. , 1986). Since then a 
number of researchers have attempted to define salt-sensitivity (Burnier et al., 
2000; de la Sierra et al., 2002; Gerdts et al., 1999; Gill et al., 1991; Larrousse et 
a/. , 2006; Overlack et al., 1993; Sullivan et a/. , 1991; Weinberger, 2006). 
Although there are several definitions suggested to identify salt-sensitive 
individuals, studies have consistently shown that hypertensive individuals are 
more frequently salt-sensitive than normotensive individuals (He et al., 1998; 
Weinberger, 2006). In addition certain population groups are also believed to be 
more at risk to develop hypertension due to Na+ intake (Campese, 1997; Wright et 
al., 2003). 
In this regard there is considerable evidence to support salt-sensitivity as an 
important pathophysiological mechanism responsible for hypertension in persons 
of African ancestry. This evidence is derived from a number of studies, many of 
which were intervention studies involving comparisons of the effect of dietary Na+ 
restriction or supplementation on BP (Aviv et a/. , 2004; Beevers, 2002; Falkner 
and Kushner, 1991; He et al., 1998; He et al., 2009; Vollmer et al., 2001; 
Weinberger et al., 1986; Wright et al., 2003). However, the mechanisms involved 
in the higher incidence of SS-HTN in groups of African ancestry are poorly 
understood. One explanation may be the fundamental differences in the kidney's 
ability to maintain Na+ homeostasis in groups of African ancestry compared to 
other ethnic groups (Bochud et al., 2009; Luff et a/. , 1982). Nevertheless in 
considering the pathogenesis of SS-HTN, some studies have suggested that it is 
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not only a high Na+ intake that is involved in the development of SS-HTN, but also 
a low K+ intake (Aviv et al., 2004; Hedayati et al., 2012; Weinberger et al., 1986). 
In this regard, studies have shown that prehistoric diets were low in Na+ and high 
in K+ intake (Eaton et al., 1988; Hunt and Cappuccio, 2014; Tobian, 1988). 
According to Darwin, the human body has been biologically designed to function 
efficiently with a low Na+ and a high K+ diet by conserving Na+ and excreting K+ 
(Tobian, 1997). In contrast to prehistoric diets, the modern westernized diet is 
extremely high in Na+ and low in K+ (Bertram et al., 2012; Jain et al., 2014; Penton 
et al., 2015). Such a diet with a chronic excess of Na + and deficit in K+ has 
reportedly been associated with SS-HTN and kidney failure (Adrogue and Madias, 
2014). The section below will focus on what is known about the pathophysiology 
of how Na+ and K+ contribute to SS-HTN. 
2.2 Sodium 
Sodium (Na+) is the principal cation in the extracellular fluid (ECF) and plays an 
essential role in the regulation of ECF volume and BP (Geerling et al., 2008; 
Robertson et al., 2003). Na+ is found in a variety of foods such as meat and 
shellfish and is very abundant in most processed foods (WHO, 2006). Data from 
around the world have reported that modern societies consume far more Na+ than 
they physiologically require (Brown et al., 2009; Capuccio and Capewell, 2015; 
Frassetto et al., 2001). Historically, Na+ was added to food for food preservation 
(MacGregor and de Wardener, 1998; Multhauf, 1978), but with modern canning, 
refrigeration and other methods of food preservation, the need for Na+ as a 
preservative has declined (Capuccio and Capewell, 2015). Nevertheless many 
people have become accustomed to the taste of Na+ which is why the 
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consumption of Na+ in modern societies exceed the current recommendations of 
less than 1.5g /day (Frassetto et a/., 2001; Kearney, 2010; Lloyd-Jones et a/., 
2010; WHO, 2013). International guidelines on cardiovascular disease prevention 
recommend reducing Na+ intake to 19/day by the year 2025, a level that has not 
been reached by any country (Appel et a/., 2011, WHO, 2013). In black South 
Africans, the average Na+ intake is 3.1 g/day (Charlton et a/., 2005), which is 
higher than the 2.4 g/day recommended by the South African Hypertension 
Guidelines (Seedat et a/., 2006; WHO, 2013). Given the high Na+ intake in modern 
society, understanding the detrimental effects of Na+ on BP is clearly of clinical 
importance. 
2.2.1 High sodium intake related increases in blood pressure 
It is generally accepted that a high Na+ consumption is associated with increased 
BP. The hypertensive effects of a high Na+ intake was first demonstrated in 1904 
by Ambard and Beaujard. Their study showed that the patients' BP was 
significantly elevated with an increased dietary Na+ intake and, inversely, lowered 
when Na+ intake was reduced (Ambard and Beaujard, 1904). Since then 
numerous epidemiological studies, meta-analyses and intervention trials have 
investigated the effects of dietary Na+ on BP (Appel et a/., 2006; Danaei et a/., 
2009; Cook et a/., 2007; Cook et aI., 2009; Umesawa et a/., 2008). 
Epidemiological studies have shown that populations consuming low levels of Na+ 
have a lower incidence of hypertension (Carvalho et a/., 1989; Denton, 1997; 
James and Baker, 1995). However when these populations migrate to western 
societies where higher Na+ levels are consumed, a significant rise in BP occurs 
(Siani et a/., 2000; Weinberger, 1996). Similarly, the large-scale International 
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Study of Salt and BP (INTERSAL T) reported a positive relationship between 
dietary Na+ intake and BP (Elliot et al., 1996). Other large population-based 
studies have confirmed the association between Na+ and elevated BP (Beard et 
al., 1997; Law et aI., 1991; Yamori et aI., 1990). A marked increase in BP due to 
high Na + intake has also been observed in cross-sectional studies (Draaijer et al., 
1995; Elliot et aI., 1996; Gerdts et al., 1994; Meneton et aI., 2005; Sharma et aI., 
1989; Rodrigues et aI., 2015). However, intervention studies examining the effect 
of high dietary Na+ intake on BP have reported conflicting results, where some 
(Sacks et al., 2001, Cappucio et al., 1997) but not others (Ruppert et al., 1993; 
Todd et al., 2012) have reported changes in BP due to Na+ intake. 
In addition, animal studies including Dahl salt-sensitive (DSS) (Dahl et al., 1962), 
spontaneously hypertensive (SHR) (Koga et aI., 2008), Sprague Dawley (SO) 
(Giardina et al., 2001; Sofala et aI., 2002) and Wistar (Huang and Johns, 2000; 
Walkowska et aI., 2015) rats and chimpanzees (Denton et al., 1995, Elliot et aI., 
2007) have mainly demonstrated that high Na + diets increase BP. Similar to 
humans, animals show varying degrees of salt-sensitivity or salt-resistance 
(Stocker et al., 2010). It is well known that the DSS rats and SHRs show large 
increases in BP with high Na+ intake (Siegel et al., 2004; Wu et al., 2000) whereas 
in SO rats the effect of high Na+ intake on BP has been inconsistent (Farjah et al., 
2004, Giardina et al., 2001, Sofola et aI., 2002, Titze et al., 2006). In this regard 
some studies have reported a moderate increase in BP with high Na+ intake 
suggesting that SO rats are salt-sensitive (Adegunloye and Sofola, 1996; Giardina 
et aI., 2001; Gu et aI., 2008). In contrast, others have found no significant changes 
in BP with a high Na+ intake (Debinski et al., 1990; Farjah et aI., 2004; Osborn and 
Hornfeldt, 1998; Titze et al., 2006), indicating that the salt-sensitivity of SO rats 
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remains controversial. Part of the controversy may be due to the different study 
protocols and short duration of the studies. Nevertheless both humans and 
animal studies convincingly show that increasing Na+ intake above the 
physiological requirements can cause an increase in BP. A number of studies 
have investigated the possible mechanisms responsible for the increase in BP in 
response to a high Na+ intake, which will be highlighted in the following section. 
2.2.2 Mechanisms of sodium-induced salt-sensitive hypertension 
Despite extensive animal and clinical investigations, the mechanisms by which the 
increase in Na+ intake leads to the development of SS-HTN are complex and not 
completely understood. Although a number of mechanisms involved in the 
development of SS-HTN have been proposed, the most frequently suggested 
mechanism seems to be the inability of the kidneys to excrete large amounts of 
Na+ leading to sodium retention (Kobori et aI., 2007; Meneton et al., 2005; Navar 
et al., 1997). Indeed the kidney is the main site for Na+ handling hence changes in 
Na+ handling by the kidney may be a causal factor in the pathogenesis of SS-
HTN. Under normal physiological conditions, high Na+ intake stimulates thirst-
induced increases in fluid intake (Stolarz-Skrzypek et al., 2013). This leads to an 
increase in blood volume which persists only for a short time until water and Na+ 
excretion restores the circulating volume and osmolality (Stolarz-Skrzypek et al., 
2013). However a decreased capacity of the kidneys to excrete Na+ leads to Na+ 
and water retention and subsequently increased ECF volume resulting in 
increased BP (Khalil, 2006; Pao, 2014). 
In addition to the fluid and Na+ regulating roles, another mechanism of SS-HTN 
driven by the kidney is via the regulation of BP by means of a variety of hormones 
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including renin, angiotensin II and aldosterone, known as the renin angiotensin 
aldosterone system (RAAS) (Crowley et al., 2005; Weinberger, 2006). The RAAS 
is a feedback mechanism that maintains BP and Na+ balance (Harrison-Bernard, 
2009). Renin is an enzyme synthesized and released from the juxtaglomerular 
cells of the kidney in response to a reduced Na+ delivery at the macula densa of 
the kidney, a decrease in renal perfusion pressure and a decrease in blood 
volume (Harrison-Bernard, 2009). Renin cleaves angiotensinogen to form 
angiotensin I which is converted to angiotensin II (Harrison-Bernard, 2009; Navar 
et al., 1996). Angiotensin II causes constriction of peripheral vessels, which in turn 
increase total peripheral resistance (TPR) (Harrison-Bernard, 2009; Navar et al., 
1996) and ultimately increases BP (Navar et aI., 1996; Visser et al., 2008). 
Angiotensin II also stimulates aldosterone production from the adrenal glands. 
Aldosterone increases renal reabsorption of Na+, with a subsequent increase in 
water reabsorption by osmosis and therefore urinary loss of Na + and water is 
reduced (Harrison-Bernard, 2009; Navar et al., 1996).This results in an increased 
blood volume which causes an increase in BP. In addition angiotensin II causes 
an increased release of antidiuretic hormone (ADH) from the posterior pituitary 
gland which increases fluid retention in the kidneys, also resulting in a greater 
blood volume and hence BP (Harrison-Bernard, 2009; Navar et aI., 1996). 
A large body of evidence has reported that salt-sensitive individuals have low 
plasma renin activity (PRA) , the standard laboratory measure of systemic RAS in 
humans (Franco and Oparil, 2006; Mulatero et al., 2007; Rayner et al., 2001; 
Sag nella, 2001; Sahay, 2012). Indeed blunted renal Na+ excretion results in an 
expansion of the ECF volume which leads to a decrease in renin release from the 
juxtaglomerular apparatus as there is a higher perfusion pressure at the 
13 
juxtaglomerular cells and supresses the activity of the systemic renin angiotensin 
system (RAS) (Visser et al., 2008; Stocker et aI., 2010; Stolarz-Skrzypek et al., 
2013; Weinberger, 2006). The reduced PRA in salt-sensitive individuals does not 
exclude local angiotensin II activity in the vascular endothelium, the kidneys, and 
the brain (Johnston, 1992; Kobori et al., 2007; Orth and Ritz, 2001). Hence it is 
therefore possible to have activation of local RAS within the kidney with 
suppressed renin in the systemic circulation (Johnston, 1992; Kobori et al., 2007; 
Orth and Ritz, 2001). Studies have reported that high Na+ intake results in 
increased activation of local intrarenal RAS which may result in increased TPR 
and BP (Kobori et al., 2010; Michel et al., 2014, Vogt et al., 2004). Similarly in rat 
studies a decreased PRA and an upregulation of intrarenal RAS in OSS rats, SHR 
and SO rats receiving a high Na+ intake has also been reported (Campbell et al., 
1996; Chandramohan et al., 2008; Kobori et al., 2003; Kobori et al., 2010; Lara et 
al., 2012). 
A third mechanism that has been suggested in the development of SS-HTN 
involves the vascular endothelium. The endothelium plays a major role in the 
maintenance of vascular tone and BP through the release of various relaxing and 
contracting factors (Bauer and Sotnikov8, 2010). The endothelium releases 
endothelial-derived relaxing factors such as nitric oxide (NO), prostacyclin and 
endothelium-derived hyperpolarizing factor (EOHF) (Bauer and Sotnikov8, 2010). 
NO is synthesized from L-arginine by an enzyme called nitric oxide synthase 
(Forstermann and MOnzel, 2006). NO diffuses from endothelial cells into the 
vascular smooth muscle (VSM) and stimulates guanylate cyclase (Bauer and 
Sotnikov8, 2010; Lucas et al., 2000). The conversion of cyclic guanosine 
triphosphate into cyclic guanosine monophosphate (cGMP) leads to the activation 
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of cGMP-dependent protein kinase which decreases intracellular Ca2+ and 
ultimately leads to VSM relaxation (Bauer and Sotnfkov8, 2010). Several 
vasodilators, including acetylcholine (ACh), are known to produce endothelium-
dependent vasodilation through the release or synthesis of NO in the endothelium 
of arteries (Ali and Schumacket, 2002; Kagota et al., 2002; Konishi and Su, 1983; 
Qiu et al., 2001). Previous studies have shown that a high Na+ intake negatively 
affects the endothelial function. Tzemos et al (2008) showed that Na+ loading (200 
mmol/day) resulted in an impaired endothelial function in sixteen healthy 
normotensive individuals. This study showed that Na+ loading was associated with 
less endothelium-dependent vasodilation in response to ACh (Tzemos et al., 
2008). In addition, Miyoshi et al (1997) reported impaired ACh-induced 
endothelium-dependent vasodilation in 6 salt-sensitive individuals. These findings 
were also confirmed by other studies that showed impaired Ach-induced 
vasodilation with high Na+ intake (Bragulat et al., 2001; DuPont et al., 2013). 
Similarly, animal studies have demonstrated that a high Na+ intake leads to an 
impaired relaxation of blood vessels to vasodilator stimuli (Fujiwara et al., 2000; 
Lenda et aI., 2000; Nashida et al., 1998; Sofola et al., 1997). High Na+ intake 
produced an impaired endothelium-dependent relaxation induced by ACh in SHR 
(Kagota et aI., 2001; Konishi and Su, 1983). Similar observations have been 
reported in DSS rats (Kobori et al., 2003; Luscher et aI., 1987). However, 
discrepancies exist in the effect of high dietary Na+ intake on vasodilation in 
normotensive SD and Wistar rats. Some studies have shown impaired 
endothelium-dependent relaxation with high Na+ intake (Banday et al., 2008; 
Giardina et al., 2001; Payne et aI., 2004) while others have reported no changes 
(Simoes et al., 2013). Nevertheless, despite the discrepancies, the majority of the 
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evidence supports the possibility that impaired endothelium-dependent 
vasodilation may occur in animals fed a high Na+ diet because of an impaired 
production of vasodilators by the endothelium (Sylvester et al., 2002; Zhu et al., 
2004). Moreover impaired endothelium-dependent vasodilation may be due to 
increased release of vasoconstrictors in response to vasoactive stimuli that 
normally causes vasodilation (Zhu et a/., 2004). 
In addition to the changes in the release of and response to local vasodilators the 
increase in BP may also be explained in part by an enhanced reactivity to the 
activation of a1-adrenergic receptors in the vessel wall (Adegunloye and Sofola, 
1997; dos Santos et al., 2005; Obiefuna et al., 1991; Sofola et al., 2002). Animal 
studies have reported that a high dietary Na+ intake increases contraction induced 
by a1-adrenoceptor agonist (Adegunloye and Sofola, 1997; dos Santos et a/., 
2006; Obiefuna et al., 1991; Sofola et al., 2002; Tanoue et a/., 2002) which 
ultimately leads to an increased TPR. Studies have reported that a high Na+ intake 
causes enhanced sensitivity to noradrenaline (Obriefuna et al., 1991) or 
phenylephrine (Smith et al., 2003) at the a-adrenergic receptor level and hence 
results in the increased stimulation of a-adrenergic receptors (Smith et al., 2003). 
The stimulation of a-adrenergic receptors by agonists such as phenylephrine and 
noradrenaline causes activation of phospholipase C and increases production of 
inositol triphosphate (IP3) and diacylglycerol (Oeth and van Breemen, 1974; Smith 
et al., 2003). IP3 and diacylglycerol act as second messengers and increases 
VSM intracellular calcium (Ca2+) concentration. Ca2+ is a key molecule in the 
contraction process where Ca2+ binds to calmodulin forming a complex which 
activates myosin light chain kinase leading to VSM contraction (Oeth and van 
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Breemen, 1974}. Hence high Na+ intake can cause increased VSM contraction 
through the activation of a-adrenergic receptors. 
In addition to the direct vasodilator and vasoconstrictor influence, a high dietary 
Na+ intake also inhibits the Na+/K+-ATPase pump which results in increased 
intracellular Na+ concentration in the VSM cells (Adrogue and Madias, 2014; 
Iwamoto and Kita, 2006). The increased intracellular Na+ concentration in turn 
stimulates the Na+/Ca2+ exchanger (which transports Ca2+ into the cells) and 
intracellular Ca2+ concentration is increased (Adrogue and Madias, 2014). With an 
increased intracellular Ca2+, tonicity of the VSM is enhanced which causes 
vasoconstriction and ultimately increased TPR and BP (Adrogue and Madias, 
2014; Blaystein and Hamlyn, 1991, Quednau et al., 2004; Iwamoto, 2006). 
In summary, Na+ results in elevated BP via a number of mechanisms. Certainly 
these mechanisms explain the development of hypertension in long term high Na+ 
exposure, but also acute changes in BP due to a Na+ load, as seen in 
normotensive individuals. However whether high Na+ intake increases BP in 
specifically normotensive rats is controversial and needs further elucidation. 
Furthermore, the mechanism involved in the possible development of high BP in 
previously normotensive animals during high Na+ exposure is unclear and needs 
further investigation. 
Despite the detrimental effects of Na+ on BP, a high Na+ intake has also been 
implicated in the development of target organ damage comprising the heart, 
kidneys and vasculature, independent of BP. These Na+-induced target organ 
changes will be discussed below. 
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2.2.3 Sodium-induced target organ damage 
2.2.3.1 The effect of high sodium intake on the heart 
Left ventricular hypertrophy detected on echocardiography is a strong and 
independent predictor of cardiovascular morbidity and mortality (Langenfeld and 
Schmieder, 1995; Schmieder and Messerli, 2000). It is well known that increased 
BP can lead to a variety of structural and functional changes in the heart, however 
elevated Na+ can also cause structural and functional changes independent of BP. 
In both normotensive and hypertensive subjects, diastolic filling and left ventricular 
mass have been found to be positively correlated with urinary Na+ excretion, 
independent of BP (Daniels et al., 1990; du Cailar et al., 1992; du Cailar et al., 
2002; Tuomilehto et aI., 2001; Schmieder and Messerli, 1988). In addition to 
human studies, studies in DSS rats (de Simone et a/., 1993), SHRs (Ahn et al., 
2004; Frohlich et al., 1993; Varagic et al., 2006) and Wistar rats (Fields et al., 
1991; Kihara et al., 1985; Lal et al., 2003) have shown increased left ventricular 
mass due to high Na+ intake. Hence high Na+ intake can cause BP-independent 
structural changes to the heart. 
2.2.3.2 The effect of high sodium intake on the kidneys 
Chronic kidney disease is a worldwide public health challenge and is associated 
with increased cardiovascular events and premature death (Couser et al., 2011; 
Sarnak et al., 2003; Stenvinkel, 2010). High Na+ intake may affect the rate of the 
progression of kidney disease through both BP-dependent and BP-independent 
effects (de Wardener and MacGregor, 2002; Heerspink et al., 2012; Marijke et al., 
2003). Human studies have demonstrated a positive relationship between high 
Na+ intake and increased proteinuria (du Cailar et al., 2002; Campese et a/., 1991; 
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Verhave et aI., 2004; Weir et aI., 2012; Yu et al., 1998), which is a major risk factor 
for the development of kidney disease (Hsu et aI., 2009; Iseki et aI., 2003). In 
animal studies, a high Na+ diet has also been associated with renal injury. Studies 
of high Na+ intake between 7 days and 16 weeks have reported renal hypertrophy 
and fibrosis in DSS rats (McCormick et al., 1989), SO rats (Gu et al., 2008), SHRs 
and Wistar rats (Kihara et al., 1985, Yu et al., 1998). Matavelli et al (2007) 
showed in SHRs that high Na+ intake resulted in increased proteinuria from the 
second week on the high Na+ diet. Similarly other animal studies have reported 
increased urinary protein excretion and decreased renal plasma flow in SHRs, 
DSS, SD, and Wistar rats (Blizard et al., 1991; Gu et al., 2008; Maitland et al., 
2006; Varagic et aI., 2006; Yu et al., 1998). Taken altogether these findings 
support the notion of a strong causal relationship between high Na+ intake and 
renal injury. 
2.2.3.3 The effect of high sodium intake on the blood vessels 
As discussed in section 2.2.2 above, Na+ has a detrimental effect on the vessels, 
which leads to the development of high blood pressure. Despite these effects a 
high Na+ intake also affects vascular function in the long term which may lead to 
arterial stiffness and endothelial dysfunction (Safar et al., 2000; Simon and Illyes, 
2001; de Wardener and MacGregor, 2002; Zhu et al., 2004). Pulse wave velocity, 
a classical measure of arterial stiffness is a strong independent predictor of 
cardiovascular risk (Blacher et aI., 1999; Glasser et al., 1997; Safar et aI., 2002). 
Although high BP is associated with the development of arterial stiffness, several 
clinical studies have shown a BP-independent correlation between Na+ intake and 
arterial stiffness (Safar et al., 2000; Mercier et al., 2007). In a study conducted by 
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Avolio and colleagues (1985), pulse wave velocity was measured in 2 groups 
living in either a rural or urban community. The pulse wave velocity after 
adjustment for BP was significantly lower in the rural community than in the urban 
community consuming high Na+. Similarly in a group of 34 hypertensive subjects, 
high Na+ intake for four weeks significantly increased pulse wave velocity (Todd et 
a/., 2010). In addition other cross sectional and intervention studies have shown 
an increase in pulse wave velocity in subjects consuming high dietary Na+ 
independent of BP (Avolio et a/., 1986; He et a/., 2009; Seals et a/., 2001; Todd et 
a/., 2010). Taken together these findings suggest that high Na+ intake has a BP-
independent effect on arterial stiffness and hence cardiovascular disease risk. 
Moreover high Na+ has been reported to cause endothelial dysfunction. 
Endothelial dysfunction plays an important role in the progression of 
atherosclerosis and predicts cardiovascular mortality (Luscher et a/., 1993; 
Shimbo et a/., 2007; Suwaidi et a/., 2000; Yeboah et a/., 2007). High Na+ intake 
has been shown to impair endothelial function assessed by flow-mediated dilation 
(FMD) (Bragulat et a/., 2001; Dickinson et a/., 2009; Tzemos et a/., 2008) a non-
invasive assessment of endothelial function (Raitakari and Celermajer, 2000; 
Shimbo et a/., 2007; Yeboah et a/., 2007). Dickinson et a/ (2011) reported reduced 
FMD within 30 minutes of a high Na+ meal. More recently, 7 days of high Na+ 
intake reduced FMD in both normotensive men and women (Lennon-Edwards et 
a/., 2014). In addition the deleterious changes in the vasculature from high Na+ 
intake have been documented in SHRs, DSS, Wistar and SD rats independent of 
BP (Frohlich et a/., 1993; Lenda et a/., 2000; Lenda et a/., 2002; Matavelli et a/., 
2007; Yu et a/., 1998; Zhu et a/., 2007). Therefore taken together these studies 
suggest that high Na+ intake has BP-independent effects on target organ damage. 
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However the majority of these studies were performed in hypertensive individuals 
and rat strains. Hence the effect of Na+ intake on target organs in normotensive rat 
strains needs further investigation. Nevertheless current and past literature richly 
reflects the importance of decreasing Na+ intake to reduce BP and associated 
cardiovascular outcomes. One potential strategy that may be effective in 
decreasing Na+ levels is to promote Na+ excretion. This leads to the importance of 
consuming adequate dietary K+ levels as it is known to have natriuretic properties 
which may reduce BP (Brandis et a/., 1972; Pamnani et a/., 2000; Perucca and 
Bankir, 2007). In contrast to the abundant literature on the effects of dietary Na+ on 
BP, dietary K+ has received less attention often being viewed as a minor factor in 
the development of SS-HTN (Adrogue and Madias, 2014; Kanbay et a/., 2013). 
However there is mounting evidence indicating a role of dietary K+ intake in BP 
regulation. The mechanisms of how dietary K+ intake leads to a decrease in BP 
will be discussed below. 
2.3 Potassium 
Potassium (K+) is the most abundant intracellular ion and is important in 
maintaining total body fluid and electrolyte balance in the body. K+ is abundant in 
beans, potatoes, mushrooms, bananas, avocados, guavas and many other fruit 
and vegetables (Cohn et aI., 2002). Despite the wide variety of foods rich in K+, 
various populations around the world consume less than the recommended 
amount of K+ (Stamler et a/., 2003; van Mierlo et a/., 2010). The current 
recommended K+ intake for adults is at least 90 mmol/day (WHO, 2012). However, 
studies done in SA ethnic groups showed that K+ consumption is below 50-70 
mmol/day especially in black Africans (Charlton et a/., 2005; Matlou et aI., 1986; 
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van Mierlo et al., 2010}. Nevertheless, studies suggested that moving towards the 
recommended K+ intake has health benefits especially in people of African 
descent at risk for the development of SS-HTN (Chobanian et al., 2003; Gupta 
and Guptha, 2010; Weaver, 2013; van Mierlo et al., 2010; Siani et aI., 1991; 
Whelton et aI., 1997; WHO, 2012). However, what is the evidence that K+ intake 
will have health benefits, specifically related to BP? 
2.3.1 High potassium intake related decreases in blood pressure 
Epidemiological, clinical and animal studies have reported that dietary K+ 
supplementation may decrease BP (Braschi et al., 2008; Gu et al., 2001; He and 
MacGregor, 2001; Kawano et aI., 1998; Khaw and Barret-Connor, 1987; Kido et 
aI., 2008). Several epidemiologic studies from widely divergent geographic 
locations have consistently showed an inverse relation between K+ intake and the 
prevalence of hypertension. A meta-analysis of 19 randomized control trials 
(RCTs) found that K+ supplementation with dosages ranging between 48 and 120 
mmol/day significantly reduced SBP by 8.2 mm Hg and DBP by 4.5 mm Hg in 
hypertensive individuals (Cappuccio and MacGregor, 1991). Another meta-
analysis of 33 RCTs showed that K+ supplementation was associated with a 
reduction in SBP by 1.8 mm Hg and 2.5 mmHg in normotensive and hypertensive 
persons respectively (Whelton et al., 1997). These studies suggest that K+ 
supplementation beneficially affects BP regulation not only in hypertensive 
individuals but also in normotensive individuals. In contrast a recent meta-analysis 
of 5 RCTs, however, found no significant effect of K+ supplementation on BP 
(Dickinson et aI., 2006). The authors acknowledged the small number of 
participants and the heterogeneity between the trials (Dickinson et al., 2006). 
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Although previous studies suggest that K+ supplementation may reduce BP, the 
results have been inconsistent across different studies in part because of different 
study protocol designs. 
Despite these inconsistencies among the general population, K+ supplementation 
significantly lowers BP among salt-sensitive individuals especially in groups of 
African descent (Fujita and Ando, 1984; Grimm et al., 1990; Liu et aI., 2013, Siani 
et aI., 1987; Svetkey et aI., 1987; Wilson et al., 1999). Studies have consistently 
showed that groups of African descent have a lower dietary K+ intake compared to 
groups of European descent (Aviv et al., 2004; Hajjar et al., 2001; Sorof et al., 
1997). This could explain why there is a higher frequency of salt-sensitivity in 
groups of African descent compared to groups of European descent (Aviv et aI., 
2004; Hajjar et al., 2001; Sowers et aI., 1988). In this regard, the extent of BP 
reduction from K+ supplementation may be greater in groups of African descent 
than in groups of European descent (Aviv et al., 2004, Hajjar et al., 2001; Whelton 
et al., 1997). I ndeed Whelton and colleag ues (1997) showed that K+ 
supplementation reduced BP to a greater extent in groups of African descent as 
compared to groups of European decent. Similarly a greater reduction of BP due 
to K+ supplementation in groups of African descent compared to groups of 
European descent has been observed in other studies (Aviv et al., 2004; Turban 
et al., 2008; Weaver, 2013). These findings suggest that BP in groups of African 
descent is particularly sensitive to K+. Furthermore these findings are important 
considering that groups of African descent have a higher prevalence of 
hypertension and are more salt-sensitive than groups of European descent. 
Animal studies have also provided convincing evidence supporting the beneficial 
role of K+ supplementation on BP (Haddy et al., 1991; Manger et al., 2003; 
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Reusser et aI., 1994; Tobian et al., 1997). In several rat models of hypertension, 
including the DSS rats (Zheng et al., 2012; Zicha et al., 2010), SHRs (Jodas et al., 
2014; Tobian et aI., 1984) and DOCA-salt rats (Wang et aI., 2005) , K+ 
supplementation decreased BP. However, K+ supplementation seems to have 
little effect on BP in normotensive rats but have protective effects on end organ 
damage (Meldrum, 1990; Rigsby et al., 2008). Rigsby and colleagues (2008) 
reported that dietary K+ intake had no effect on BP in normotensive Wistar rats, 
however it improved cerebral vascular structure and reduced the amount of 
damage caused by cerebral ischemia in normotensive rats (Rigsby et al., 2008). 
Below is an overview of some of the possible mechanisms of the antihypertensive 
effects of K+ supplementation. 
2.3.2 Mechanisms of the antihypertensive effect of potassium 
supplementation 
A number of possible underlying mechanisms for the antihypertensive effect of K+ 
supplementation have been reported, including enhanced natriuresis (Brandis et 
aI., 1972; Pamnani et aI., 2000; Perucca and Bankir, 2007), reduced renal renin 
release (Bauer et al., 1979; Penton et aI., 2015) and improved vasodilation 
(Amberg et aI., 2003, Haddy et al., 2006). Firstly, several studies suggest that K+ 
supplementation causes natriuresis and is thought to be mediated by an inhibition 
of Na+ reabsorption in the proximal tubules of the kidneys (Brandis et al., 1972; 
Pamnani et al., 2000, Perucca and Bankir, 2007). Indeed K+ supplementation in 
dogs (Keith and Binger., 1935) and rats (Vander, 1970; Wright et al., 1971) 
produced prompt natriuresis. 
Secondly, given both acutely and chronically K+ acts directly on the kidneys to 
inhibit renin release (Bauer et al., 1979; Penton et al., 2015; Vander, 1970). 
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Although the mechanisms are only partially understood, the suppression of renin 
release by K+ supplementation may result from a depression of proximal tubule 
Na+ reabsorption and an increased Na+ delivery to the macula densa of the kidney 
(Sealey et aI., 1970; Vander, 1970). 
In addition, K+ supplementation plays an essential role in the regulation of 
vascular tone (Stolarz-Skrzypek et aI., 2013). Several studies have shown that K+ 
supplementation improves vascular relaxation by increasing the generation and 
release of NO (Zhou et al., 1999; Zhou et al., 2000). Zhou and colleagues (2000) 
reported that K+ supplementation improves endothelium-dependent release of NO 
and vasodilation in carotid arteries of OSS rats. (Zhou et aI., 2000). A number of 
studies showed similar results in the aortas of OSS rats (Raij et al., 1988; Sudhir 
et al., 1993). Furthermore, others have suggested that K+ causes endothelial 
dependent vasodilation by hyperpolarizing the endothelium through the activation 
of the Na+/K+-ATPase pump (Amberg et al., 2003; Edwards and Weston, 2004; 
Haddy et al., 2006; Houston et al., 2011). The Na+/K+-ATPase pump has important 
effects on the contractile state of VSM, which in turn influence blood flow and BP 
(Haddy, 1983). Activation of the Na+/K+-ATPase pump results in the 
hyperpolarization of the vascular smooth muscle cells, decreases cytosolic 
Ca2+concentration, promotes vasodilatation and hence decreases TPR and BP 
(Amberg et al., 2003; Busse et al., 2002; Haddy et al., 2006; Houston, 2011; 
McGuire et al., 2001). 
2.3.3 Protective effects of K+ supplementation on cardiovascular diseases 
In addition to its effect on BP, there is evidence suggesting that K+ 
supplementation reduces the risk of stroke (O'Elia et al., 2011; Larsson et aI., 
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2011; O'Donnell et aI., 2011) and prevents kidney damage through BP-
independent mechanisms (Mattheson et a/., 2012). The cardio-protective effects of 
K+ supplementation have been hypothesized as the basis for the low CVD rates in 
populations consuming vegetarian diets (Reddy and Kata, 2004; Ascherio et a/., 
1991). Khaw and Barrett-Connor (1987) found that a 10-mmol/day of K+ 
supplementation was associated with a 40% reduction in stroke-associated 
mortality independent of other known cardiovascular risk factors, including 
hypertension. The Framingham Study also reported a BP-independent 22% 
reduction in the risk of stroke associated with an increased K+ intake (Gillman et 
aI., 1995). Furthermore, studies in hypertensive rats have shown that high K+ 
intake prevents the development of renal vascular, glomerular and tubular 
damage (Ellis et aI., 1992; He and Macgregor, 2008; Tobian et a/., 1984; Wang et 
a/., 2005). In addition K+ supplementation protects against excess Na+-induced 
vascular cardiac diastolic dysfunction in DSS rats (Matsui et a/., 2006) and 
reverses cardiac hypertrophy in DOCA-salt induced rats (Wang et a/., 2005). 
Taken together, the above findings suggest that K+ supplementation may provide 
protection not only against BP but also CVD. 
In addition to its positive effects on lowering BP, K+ supplementation can mitigate 
the negative effects of elevated Na + consumption on BP (Bulpitt, 2000; Morris et 
a/., 1999). In an intervention study conducted by Sacks and colleagues (2001), 
421 pre-hypertensive and hypertensive individuals were randomly assigned to eat 
either a typical United States (control) diet or the Dietary Approaches to Stop 
Hypertension (DASH) diet with high, intermediate or low Na+ intake. The DASH 
diet is rich in fruit, vegetables, plant based proteins, whole grains and low-fat dairy 
foods rich in K+ (Appel et a/., 1997; Sacks et a/., 2001). Sacks et aI., (2001) 
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reported that the DASH diet had a more pronounced effect on the high Na+ intake 
compared to the low Na+ intake groups (Sacks et aI., 2001). Furthermore they 
concluded that a reduction in Na+ intake below the recommended 5 g/day in 
addition to consuming the DASH diet has greater effects on BP in combination 
than either intervention alone (Sacks et al., 2001). Similarly numerous other 
studies have shown that a low Na+ diet combined with the DASH diet has 
beneficial effects on BP (Bray et aI., 2004; Du et aI., 2014; Svetkey et al., 2004; 
Taylor et al., 2010; Vollmer et al., 2001). These studies indicate that dietary K+ 
intake in addition to Na+ intake, may be important when assessing the overall 
effect on BP and cardiovascular disease risk. In this regard the Na+ to K+ urinary 
excretion ratio (Na+/K+) has become an increasingly important marker of BP and 
CVD risk as studies have shown that a high Na+/K+ correlates significantly with an 
increased SBP and an increased risk of CVD (Cook et al., 2009; Scott et al., 
2011). The section below will highlight the evidence for the importance of 
considering the Na + /K+ in association with BP and CVD risk. 
2.4 Sodium-to-potassium ratio 
The urinary Na+/K+ is determined from the collection of urine over a 24 hour 
period. Total body Na+ and K+ are tightly controlled by the kidneys therefore the 
levels of these electrolytes in urine are considered to be adequate reflections of 
dietary intake of these ions (Adrogue and Madias, 2007; Cook et al., 2009; 
Geleijnse et al., 2007; Guyton 1981). A number of studies have utilized the Na+/K+ 
to quantify Na+ and K+ intake and its relationship with BP and CVD risk. Khaw and 
Barrett-Connor (1988) were some of the first researchers to show stronger 
correlations of the Na + /K+ with BP than either electrolyte alone (Khaw and Barret-
Connor, 1988). Similarly, data from the INTERSAL T study showed that a high 
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Na+/K+ significantly correlated with SBP and DBP (INTERSALT, 1988). Other 
large scale population based studies have shown similar results where a higher 
Na+/K+ was more strongly associated with increased BP than either Na+ or K+ 
alone (Cook et al., 2007; Smith et aI., 1988). 
The risk of CVD and the Na+/K+ has also been assessed in a meta-analysis using 
the National Health and Nutrition Examination Survey (NHANES) III data (Yang et 
aI., 2011). This study found that in a United States (U.S) population of all age 
groups, a higher Na+/K+ was associated with a significant increase in risk of CVD 
(Yang etal., 2011). 
A number of cross-sectional studies provide additional support for an elevated 
Na+/K+ as a superior metric to either Na+ or K+ alone in the evaluation of BP 
outcomes (Du et aI., 2014; Morris et aI., 2006; Taylor et aI., 2010). Table 2.1 
summarizes the association of the Na+/K+ with BP in cross-sectional studies. 
Majority of the studies reported in Table 2.1 show that hypertensive individuals 
had higher Na+/K+ compared to normotensive individuals (Hedayati et aI., 2012; 
Hu and Tian, 2001; Huggins et al., 2011; Polonia et al., 2006; Zhang et al., 2013). 
However, some of these studies were limited by the lack of control for confounding 
variables such as cardiovascular risk factors (Polonia et al., 2006; Hu and Tian, 
2001), lack of urine collection (Du et aI., 2014; Hu and Tian, 2001; Kim et aI., 
2014; Ruixing et al., 2008; Zhang et al., 2013) and of 24-hour urinary Na+ and K+ 
excretion (Du et al., 2014; Hu and Tian, 2001; Kim et aI., 2014; Ruixing et al., 
2008; Zhang et al., 2013), over and underestimation of Na+ and K+ intake (Du et 
al., 2014; Hu and Tian, 2001; Ruixing et aI., 2008) and heterogeneous study 
designs (Polonia et al., 2006). 
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Table 2.1 Summary of cross-sectional studies on the association of the sodium-to-potassium ratio on blood pressure. 
Authors Number of Main findings 
participants, % 
hypertensive 
Du et al., 2014 16869 The study showed a significant interaction between the Na + /K+ and BP. 
10.4% HT 
Hedayati et al., 3303 SBP j by 1.58 mm Hg per 3-unit jin Na+/K+. The Na+/K+ was higher in HT 
2012 36%HT subjects. 
Hu and Tian, 762 HT HT subjects had higher Na+/K+. The Na+/K+ was positively associated with j BP in 
2001 1306 NT both HT and NT subjects. 
Huggins et a/., 587 HT subjects had higher Na+/K+. The Na+/K+ was strongly associated with SBP in all 
2011 43% HT adjusted and unadjusted models. 
Kim et a/., 6283 NT Na+/K+ positively related to BP in men. 
2014 
Polonia et al., 426 Na+/K+ was significantly higher in HT subjects 
2006 
Ruixing et a/., 1669 Na+/K+ positively associated with BP in both male and females 
2008 34% HT 
Zhang et al., 10563 Mean Na+/K+ was higher in HT subjects. Na+/K+ was strongly associated with SBP 
2013 2178 HT (1.05 mm Hg for every 0.5 unit j in the Na+/K+). 
(HT) hypertensive; (NT) normotensive; (Na+/K+ ) sodium-to-potassium ratio; (BP) blood pressure; (SBP) systolic blood 
pressure 
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In addition due to the cross-sectional nature of these studies the cause and effect 
cannot be inferred. Furthermore as mentioned previously the high Na+ and low K+ 
content that characterizes diets of modern societies is believed to contribute to 
SS-HTN, especially in groups of African ancestry that are considered to be more 
salt-sensitive. Therefore it is important to consider intervention studies assessing 
the effect of these dietary cations on BP. In this regard several intervention studies 
have investigated the effects of varying dietary consumption of Na+ and K+ on BP. 
Table 2.2 summarises the intervention studies on the effects of a high Na+ and a 
low K+ diet on BP in humans where both Na+ and K+ intake were controlled. Some 
of these intervention studies showed that a low K+ diet exacerbates Na+-induced 
increases in BP in both normotensive and hypertensive adults. However most of 
these studies nonetheless had very small sample sizes (Coruzzi et aI., 2001; 
Krishna and Kapoor 1991; Krishna et aI., 1989; Lawton et aI., 1990), had a short 
duration (Coruzzi et aI., 2001; Gallen et aI., 1998; Krishna and Kapoor 1991; 
Krishna et al., 1989; Lawton et aI., 1990) or did not have prospective follow ups 
(Gallen et aI., 1998; Krishna and Kapoor 1991; Krishna et al., 1989; Morris et al., 
1999). In addition the possible mechanisms responsible for these associations are 
not clear. Moreover due to practical and ethical considerations, long-term Na+ 
loading or K+ restrictions and direct assessments of end-organ damage from 
tissue samples cannot be carried out in human intervention studies. Hence animal 
intervention studies are required to appropriately assess the impact of variations in 
Na + and K+ intake on BP. 
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Table 2.2 Summary of intervention studies on the effect of a high Na+ and a low K+ diet on BP in normotensive and hypertensive 
subjects. 
Authors Subjects Study Diet Findings 
duration 
Coruzzi et 11 HT 10 days 200 mmol/day Na+ + 18 High Na+ and low K+ intake i SBP by ± 5mm Hg. 
a/., 2001 mmol K+ 
Gallen et a/., 21 NT 9 days 180 mmol/day Na + + 20 High Na + and low K+ i MAP 
1998 mmol/day K+ 
Krishna et 10 NT 9 days 200 mmol/day Na+ + 10 With high Na+ and low K+, MAP i by 5mm Hg and permits 
a/., 1989 mmol/day K+ further i in BP after saline infusion. 
Krishna and 12 HT 10 days 120 mmol/day Na+ + 16 With high Na+ and low K+ intake, SBP i by 7mm Hg and DBP i 
Kapoor 1991 mmol/day K+ by 6 mm Hg. Low K+ diet permits further i in BP after saline 
infusion. 
Lawton et a/., 11 BHT 6 days 400 meq Na + + 30 meq K+ Ambulatory SBP i in both BHT and NT subjects. MAP was i in 
1990 10 NT the BHT subjects however no significant differences were 
observed in the NT subjects. 
Morris et a/., 38 NT 10 weeks 15 mmol/day Na+ + 30 Na+ loading induced i in BP when K+ was low (30mmol/day). 
1999 mmol/day K+ 
Last 4 weeks 
'-------
250 mmol/day Na + 
---- ------------
(HT) hypertensive; (NT) normotensive; (BHT) border-line hypertensive; (BP) blood pressure; (SBP) systolic blood pressure; 
(MAP) Mean arterial pressure 
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In contrast to the abundant literature on the high Na+/K+ ratio and BP in human 
studies, evidence in animal studies is limited. Table 2.3 summarizes the effect of a 
high Na+ and a low K+ diet on BP in animal studies. The studies reported in Table 
2.3 show that in the hypertensive rat strains, a high Na+ and low K+ diet increases 
BP (Dietz et al., 1984; Wu et al., 1995; Wu et al., 1996; Wu et aI., 2000). In SHRs 
and DSS rats a low K+ diet exacerbates hypertension when administered in 
combination with a high Na+ diet (Dietz et al., 1984; Wu et aI., 1995; Wu et aI., 
1996; Wu et aI., 2000). Furthermore the increased BP reported in these rat 
strains is also responsible for renal vascular and functional alterations (Wu et aI., 
1996; Wu et aI., 2000), which could be mediated at least in part by increased 
sympathetic activity (Dietz et al., 1984; Wu et al., 2000). 
However in the normotensive rat strains the effect of a high Na+ and a low K+ diet 
on BP has been inconsistent (Dahl et al., 1972; Dietz et al., 1984; Ray et aI., 
2001). While a high Na+ and a low K+ diet had no effect on BP in WKY rats (Dietz 
et al., 1984), the diet had significant effects on BP in weanling SO rats (Dahl et aI., 
1972; Ray et al., 2001). Therefore the evidence in hypertensive rat strains seems 
to agree, but in normotensive rat strains further elucidation is needed. In addition, 
although these animal studies have demonstrated that a low K+ exacerbates high 
Na+-induced increases in BP, these studies have some limitations. Hypertension is 
uncommon in young humans and is more common in older humans, yet most of 
these studies were conducted in weanling rats (Dahl et al., 1972; Ray et al., 2001; 
Wu et aI., 1995; Wu et al., 1996; Wu et aI., 2000). Hence more studies are needed 
in adult rats to mimic the clinical situation usually encountered in adult humans. In 
addition most of these studies were done in DSS rats which are well-known salt-
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sensitive rats (Wu et aI., 1995; Wu et a/., 1996; Wu et aI., 2000) and the effects of 
a westernized diet in adult normotensive rats are not certain. 
To my knowledge, only 3 studies have examined the effects of a high Na+/K+ on 
BP in normotensive rat strains. Indeed it is important to examine the effect of 
dietary Na+ and K+ on BP in normotensive rats as normotensive salt-sensitivity 
predicts future SS-HTN (Barba et aI., 1996; Morris et a/., 1999; Sullivan, 1991). 
Moreover, most of the studies that do examine the effects of a high Na+ and low 
K+ intake on BP in normotensive rat strains did not evaluate the possible 
mechanisms responsible for the changes in BP. Consequently more animal 
studies are needed to assess the effect of low dietary K+ intake on BP and end-
organ damage. Although some studies have reported increased BP and SS-HTN 
after a period of Na+ loading (Dahl et a/., 1972; Ray et a/., 2001; Wu et a/., 1995; 
Wu et aI., 1996; Wu et a/., 2000), others have not shown this result (Dietz et a/., 
1984). Indeed in an attempt to develop a salt-sensitive model of hypertension in 
rats, in previous studies in our laboratory we have assessed the impact of dietary 
Na+ load on BP in the supposedly salt-sensitive SHRs. However, despite these 
numerous approaches, we have not been successful in producing an increase BP 
in response to a Na+ load (unpublished data). A possible reason for the lack of 
increased BP with a Na+ load is the high K+ content of the commercially available 
rat chow which could blunt the effects of Na+ loading on BP in rats. 
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Table 2.3 Summary of animal studies on the effect of a high Na+ and a low K+ intake on BP. 
Authors Strain Study Age Diet Findings 
duration 
Dahl et aI., SO 12 Weanling 4.5% Na+ + 0.57% K+ BP greater in rats receiving 
1972 months (specific age not 4.5% Na++ 1.91% K+ less K+. 
given) 4.5% Na+ + 5.74% K+ salt-sensitive rats had 
higher Na+ to K+ ratio 
Dietz et al., SHR 4 weeks 7-11 weeks 1000mmol/kg Na+ + 100 mmol/kg K+ High Na+-Iow K+ diet j BP 
1984 WKY in SHR rats but no effect in 
650mmollkg Na+ + 250 mmol/kg K+ WKY rats 
Ray et al., SO 4 weeks Weanling 3 weeks j BP in K+ deficit diet. 
2001 (specific age not Control (0.3% Na+ +0.05% K+) 
given) K+ deficit (0.3% Na+ +< 0.05% K+) j BP on 6% Na+ + 0.5% K+ 
After 3 weeks 
6% Na+ + 0.5% K+for 1 week 
Wu et al., 1995 DSS 4 weeks Weanling 8% Na+ + 0.2 % K+ Diet jBP in both DSS and 
DSR (specific age not DSR rats 
given) BP higher in DSS rats than 
DSR rats. 
Wu et al., 1996 DSS 4 weeks Weanling 8% Na + + 0.2 % K+ Hypertension induced in 
DSR (specific age not DSS and DSR rats. 
given) 
Wu et aI., 2000 DSS 4 weeks Weanling (4- 8% Na+ + 0.2% K+ Hypertension induced in 
DSR week old) DSS and DSR rats. 
(j) increase; (BP) blood pressure; (SHR) spontaneously hypertensive rats; (WKY) Wistar Kyoto; (SO) Sprague-Dawley; 
(DSS) Dahl salt-sensitive; (DSR) Dahl salt-resistant 
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Hence more studies are needed in order to establish an appropriate model of salt-
sensitivity in rats and to evaluate possible mechanisms involved in SS-HTN. 
Furthermore the impact of a low dietary K+ intake in addition to a high Na+ load in 
establishing SS-HTN in normotensive rats needs to be investigated. This knowledge 
will improve our understanding of the effects of an urbanized lifestyle with a high Na+ 
and a low K+ intake especially in black populations who are believed to be more salt-
sensitive. 
2.5 Problem statement 
SS-HTN is a major risk factor for morbidity and mortality in South Africans, 
specifically in groups of African descent. Indeed the role of increased dietary Na+ 
intake has been studied extensively and suggests that high Na+ intake does not only 
have adverse effects on BP but also on the vasculature. Additionally an inverse 
correlation between dietary K+ intake and the prevalence of SS-HTN has been 
documented. Several studies in humans and various rat strains have reported that 
increases in K+ intake attenuates increases in BP and has protective effects on the 
vasculature. However little is known about the effect of a low dietary K+ intake on BP, 
specifically in normotensives. Furthermore while these two electrolytes have been 
independently studied in relation to BP, mounting evidence suggests that the 
interaction between Na+ and K+ may be more important than their independent effects 
on BP. A combination of high Na+ intake and low K+ intake may have additional 
effects on BP than either high Na+ or low K+ intake alone. However to date, most 
human research that has looked at the combined effects of these electrolytes on BP 
have been cross-sectional studies where conclusions regarding the cause and effect 
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cannot be drawn. Secondly in animal models, majority of the studies used OSS rats 
or SHRs which are well-known model for SS-HTN. Only a limited number of studies 
that are confounded by methodological issues are available in normotensive rat 
strains. Moreover the mechanisms by which low K+ intake might increase BP are not 
well understood. Hence as normotensive salt-sensitivity is a precursor for the 
development of SS-HTN, more studies are needed in normotensive rat strains to 
assess the effects of these electrolytes on BP and the possible underlying 
mechanisms. Therefore the purpose of the present study is to establish an 
appropriate model of salt-sensitivity in rats by evaluating whether K+ intake affects the 
BP response to a high Na+ intake in male, normotensive SO rats. The aims of the 
present study can therefore be summarised as follows: 
2.6 Aims 
1. To determine the effect of high Na+ dietary intake on BP in normotensive SO 
rats 
2. To determine whether a decrease in K+ intake would exacerbate the high Na+-
induced increases in BP in normotensive adult SO rats. 
3. To determine whether Na+ induced BP changes are associated with changes 
in cardiac structure and function and in the vasculature. 
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CHAPTER 3 
MATERIALS AND METHODS 
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3.1 Animals 
Thirty-six, four-month-old male SD rats weighing 520-540 g were obtained from the 
Central Animal Service (CAS) unit of the University of the Witwatersrand. Animals 
were housed individually in cages in a temperature-controlled room with a 12 hour 
light-dark cycle. All protocols were approved by the Animal Ethics Screening 
Committee (AESC) of the University of the Witwatersrand (AESC number: 
2014/07/C). 
3.2 Experimental design 
An outline of the experimental design is presented in Figure 3.1 below. The rats had 
two weeks of a familiarization period. During this time, all the rats had ad libitum 
access to drinking water as well as standard rat chow with normal concentrations of 
K+ (1.6%) and Na+ (0.3%). Food and water intake was monitored daily by weighing 
the respective containers using a digital scale (Snowrex Electronic Scale, Clover 
Scales, Johannesburg South Africa). After the two week familiarization period, rats 
were randomly divided into three groups, each with a sample size of twelve rats. The 
groups were as follows: standard diet (CON), normal potassium-high sodium diet 
(NK+- HNa+) and low potassium-high sodium diet (LK+- HNa+). 
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36 male 4 month-old SO rats 
t= -2 w., non-invasive measurement of BP 
I 
I t= 0 w., Diet intervention I I J 
I 
CON NK+· HNa+ LK+· HNa+ 
+ + + + (normal K / (normal K / high (low K / high Na 
+ + diet) normal Na diet) Na diet) 
n=12 n=12 n=12 
I 
No change in diet + + gradual increase of Na to gradual increase of Na to 
6% (every 2 weeks) 6% (every 2 weeks) 
I 
non-invasive measurement of BP, body weight 
l EJ)w, t~Ll]lin~JiQnl 
I 
Echocardiography / blood and tissue collection / blood vessel reactivity 
Figure 3.1 A schematic outline of the experimental design and group division with 
dietary changes. 
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3.3 Diet intervention 
The rats in the CON group received a standard diet with normal K+ (1.6%) and 
sodium (0.3%) concentrations. The diets of the NK+- HNa+ and LK+- HNa+ groups 
were incremented with 2% Na+ every 2 weeks for 6 weeks as outlined in the table 
below (Table 3.1). The rats in the NK+- HNa+ group received a diet with normal K+ 
(1.6%) and high Na+ (2 to 6%) concentrations. The rats in the LK+- HNa+ group 
received a diet with low K+ (0.01 %) and high Na+ (2 to 6%) concentrations. The 2%, 
4% and 6% Na+ concentrations equate to 0.34mol/kg, 0.68mol/kg and 1.03mol/kg of 
Na+ respectively. Na+ content of 6-8% in rat food is considered an adequate Na+ load 
(Gu et aI., 2008; Kido et aI., 2008; Sofala et aI., 2003). Hence the 6% Na+ diet was 
used to ensure that rats receive an adequate Na+ load to cause cardiovascular 
changes. 
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Table 3.1 An outline of the dietary intervention for the three groups. 
CON NK+· HNa+ LK+· HNa+ 
Familiarization Normal K+ Normal K+ (1.6%) Normal K+ 
period Week -2 to week 0 (1.6%) / / normal Na+ (1.6%) / normal 
normal Na+ (0.3%) diet Na+ (0.3%) diet 
(0.3%) diet 
Normal K+ (1.6%) Low K+ (0.01 %) / 
Week 0 to week 2 /2% Na+ 2% Na+ 
Diet No change in Normal K+ (1.6%) Low K+ (0.01 %) / 
intervention Week 2 to week 4 diet /4% Na+ 4% Na+ 
Normal K+ (1.6%) Low K+ (0.01 %) / 
Week 4 to week 6 /6% Na+ 6% Na+ 
3.4 Diet composition and preparation 
During the familiarization period all the rats received commercial rat chow (Epol, 
Centurion, South Africa) which contained 1.6% K+ and 0.3% Na+. During the dietary 
intervention the animals received a K+ deficient diet (MP Biomedicals, Fountain 
Parkway, United States) which contained 0.01 % K+ and 0.3% Na+. The K+ deficient 
diet was in powder form and 5% water was added to mix. NaCI and KCI were added 
to the K+ deficient diet according to the groups' requirements. The rat food was 
prepared into small pellets and the pellets were allowed to dry for 2 days. 
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3.5 Measurements and procedures 
3.5.1 Non-invasive blood pressure (BP) measurements 
Systolic and diastolic BP was measured once a week using a tail-cuff technique 
which employs Volume Pressure Recording (VPR) technology (non-invasive CODA 
BP system, Kent Scientific) (Feng and DiPetrillo, 2009). The apparatus calibrated 
automatically. The VPR sensor utilizes a specially designed differential pressure 
transducer to non-invasively measure the blood volume in the tail. VPR utilizes a 
volumetric method to measure the blood flow and blood volume in the tail. Rats were 
habituated for two weeks before the first measurement in order to enable them to 
adapt to the procedure. To obtain BP, a conscious rat was placed in a restrainer. 
Measurements were taken at midday to avoid diurnal variation. BP was determined 
by the mean of 10 readings. 
3.5.2 Echocardiography 
After the six week dietary intervention, two-dimensional targeted M-mode 
echocardiography was performed using a 7.0 MHz transducer and a ACUSON 
CYPRESS portable ultrasound machine (Siemens Medical Division, USA), as 
previously described (Woodiwiss et a/., 2001, Norton et a/., 2002). Rats were 
anaesthetised 15 minutes before the procedure by intramuscular injections of 
ketamine (100mg.kg-1) and xylazine (5mg.kg-1). Once the rats were under 
anaesthesia, final body mass was recorded. The chest of the rat was shaved and the 
rat was placed in a prone position in a container with an open window over which the 
chest area was positioned. The high resolution ultrasonic probe was placed on the 
chest wall of the rat to obtain echocardiographic images. 
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considered to be of high quality if the endocardial surface of both the anterior wall 
and the posterior wall were clearly visible throughout systole and diastole (Figure 
3.2). Left ventricular internal dimensions and posterior wall thickness were measured 
at the end of systole and at the end of diastole according to the American Society for 
Echocardiography's leading edge method (Sahn et al., 1978) . 
Figure 3.2 Typical M-mode echocardiographic image of the left ventricle in a male 
Sprague Dawley rat. A = left ventricular end diastolic internal diameter (LVEDD), B = 
left ventricular end systolic diameter (LVESD) , C = left ventricular end diastolic 
internal diameter posterior wall thickness (LVEDD PWT), D = left ventricular end 
systolic posterior internal diameter wall thickness (LVESD PWT). 
Left ventricular endocardial fractional shortening (FSend) and midwall fractional 
shortening (FSmid) were the indices used to determine chamber and myocardial 
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Left ventricular endocardial fractional shortening (FSend) and midwall fractional 
shortening (FSmid) were the indices used to determine chamber and myocardial 
function, respectively (Norton et al., 2002). The equations below were used to 
calculate the FSend and FSmid . 
FSend = LV EDD-LV ESD 
X 100 
LVEDD 
Where 
LVEDD = Left ventricular end diastolic internal diameter 
LVESD = Left ventricular end systolic internal diameter 
FSmid = (LV EDD+LVED PWT)-(LV ESD+LVES PWT) 
X 100 
(LV EDD +LVED PWT) 
Where 
LVED PWT = Left ventricular end diastolic posterior wall thickness 
LVES PWT = Left ventricular end systolic posterior wall thickness 
3.5.3 Blood and urine sampling 
Blood was obtained at termination by cardiac puncture. 4 ml of whole blood was 
centrifuged for 10 minutes at 1400 rpm and 2 ml of serum was collected and stored at 
-20°C until analysis. Blood samples were used to determine creatinine clearance. 
Urine sampling was done at the end of the 6 week dietary intervention. Rats were 
placed individually in a metabolic cage overnight for 12 hours (fasted but with access 
to water). Urine was collected the following morning using a measuring cylinder, 
centrifuged for 10 minutes at 1400rpm and stored at -20°C until analysis. Urine 
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samples were used to determine creatinine clearance and 24-hour Na+ and K+ output. 
Creatinine clearance was used to estimate the glomerular filtration rate. The equation 
below was used to calculate creatinine clearance (EI Salam et a/., 2014). 
Creatinine clearance = Urine creatinine (mmol) Urine volume (ml) 
Serum creatinine (mmol) X Time (hours) X 60 
3.5.4 Tissue sample measurements 
Immediately after echocardiography, the rats were administered more anaesthetic 
and the hearts and right kidneys were harvested from the animals and weighed. The 
left and right ventricles were separated and weighed. 
Tibia from the left leg was de-fleshed, using a scalpel, and the length measured with 
a string and ruler. The tibial length was measured to account for variations in the 
growth of rats. According to Yin and colleagues (1982), the measurement of tibia 
length reflects a better reference of body size as it can represent relative lean body 
size throughout the life of the rat and it is said to be physiologically linked to the 
metabolic demands exerted on the heart by the body. 
3.5.5 Vascular reactivity 
After the echocardiography, the anaesthetised rats underwent a thoracotomy and the 
heart was removed from the thoracic cavity. Thoracic aorta, kidneys and mesentery 
were also removed and placed in a cold modified Krebs-Ringer bicarbonate (control) 
solution (mmolll: 118 NaCI, 4.7 KCI, 2.5 CaCI2, 1.2 MgS04, 1.2 KH2P04, 25 
NaHC03, and 11.1 glucose). Arteries were then isolated. Rings of renal and 
mesenteric arteries (2 mm long) were cleaned of fat and connective tissue and 
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suspended in a wire myograph (model 610M, Danish Myo Technology, Aahrus, 
Denmark). The Wire Myograph system is designed to measure the reactivity of small 
isolated blood vessels of 100 IJm to 2 mm in diameter. Arteries were mounted as a 
ring and threaded over two parallel stainless steel wires. The wires were secured to 
two supports or "jaws" with one support attached to a precision micrometer (allowing 
manual control of vessel circumference and stretch). The other support was attached 
to a force transducer for measurements of force/tension development. Mounted 
arterial segments were then immersed in organ chambers containing Krebs buffer 
(37°C) aerated with 95% O2 and 5% CO2. The rings were stretched progressively to 
their optimal resting tension and were allowed to equilibrate for 60 minutes. Active 
force developments of ~ 2 mN in mesenteric arteries and ~ 2.5 mN in renal arteries 
were considered optimum for experiments to proceed. KCI (80mM) was used to 
induce contraction and to check the viability of the preparations. 
Vasoactive drugs were then added into the chamber and the concentration-response 
(contractions or relaxations) curves of the preparation for the different vasoactive 
drugs were determined under isometric conditions (Christon et al., 2005). Contraction 
responses to Phenylephrine (Sigma, St. Louis MO) (Phe, 1 nM - 0.1 mM) and 
Potassium chloride (KCI, 1 mM to 120mM) were recorded. Blood vessels were dilated 
with Acetylcholine (Sigma, St. Louis MO) (ACh, 0.1 nM to 100 IJM) and Sodium 
nitroprusside (Sigma, St. Louis MO) (SNP, 1 nM to 1001JM) under phenylephrine-
induced contraction (Phe concentration=0.3-1IJM). ACh is an endothelium-dependant 
vasodilator and SNP is an endothelium independent vasodilator. 
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3.6 Data analysis 
Data analysis was performed using SAS software v. 9.3 (SAS institute Inc, Carry, 
NC). Data was expressed as means ± SEM. A one-way analysis of variance 
(ANOVA) with a Tukey post hoc test was used to determine differences in vascular 
reactivity, urinary Na+/K+ excretion, kidney and cardiac weight weights, left ventricular 
diameters and systolic and diastolic function between the groups. A repeated 
measure two-way ANOVA followed by a Tukey post hoc test was used to determine 
differences in body weights, systolic and diastolic blood pressures, food and water 
intake over the six week dietary intervention. Differences were considered statistically 
significant at P :::; 0.05. 
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CHAPTER 4 
RESULTS 
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4.1 The effect of a high sodium and low potassium diet on water intake, food 
intake and body weight 
The effects of variations in dietary sodium and potassium on weekly water intake, 
food intake and body weights during the 6 week dietary intervention are shown in 
Figure 4.1. Following the 6 week dietary intervention, weekly water intake (Figure 4.1 
A) was significantly increased in the NK+- HNa+ and LK+- HNa+ groups compared to 
the CON group (P<0.0001). The water intake was significantly increased in the NK+-
HNa+ and LK+- HNa+ groups from week 1 to 6 compared to week 0 (P<0.0001), but 
there was no change in water intake for the CON group over time. No significant 
differences in weekly water intake were observed between the NK+- HNa+ and LK+-
HNa+ groups (P>0.05). Food intake (Figure 4.18) was significantly decreased in the 
NK+- HNa+ and LK+- HNa+ groups compared to the CON group during the first week 
of the dietary intervention (P=0.03 and P=0.05 respectively). For the rest of the study 
duration there were no differences between the groups or over time compared to 
week 0 for any of the groups (all P>0.05). Following the 6 week dietary intervention 
the average Na+ intake (mmollday) in the NK+-HNa+ and LK+-HNa+ was 33.85 ± 1.20 
and 34.12 ± 1.59 respectively. Despite differences in water and food intake, there 
were no significant differences in body weight (Figure 4.1 C) between the study 
groups (P >0.05).No significant differeneces in tibia lengths (mm) were observed 
between the study groups (CON= 47.8; NK+-HNa+= 48.4; LK+-HNa+ = 48.1; P>0.05). 
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Figure 4.1 Changes in weekly water intake (A), food intake (8) and body weights (C) in 
male Sprague-Dawley rats. Data expressed as means ± SEM, n=12 per group. **P< 0.001 
# 
NK+-HNa+ and LK+-HNa+ groups versus CON group. P < 0.01 changes over time in the 
NK+-HNa+ and the LK +-HNa+ group versus week O. *P < 0.05 NK+-HNa+ and LK+-HNa+ 
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groups versus CON group. CON, normal potassium-normal sodium diet; NK+-HNa+, normal 
potassium-high sodium diet; LK+-HNa+, low potassium-high sodium diet. 
4.2 The effect of a high sodium and low potassium diet on urinary 
parameters 
The effects of the dietary sodium and potassium intervention on the urine volume, 
urinary sodium excretion, urinary potassium excretion and urinary sodium to 
potassium ratio (Na+/K+) at termination are shown in Table 4.1. After 6 weeks of the 
dietary intervention, no significant differences were observed in urine volume 
between the different groups (P> 0.05). The UN/ was significantly greater in the NK+-
HNa+ and LK+-HNa+ groups compared to the CON groups (both P< 0.0001). The UK+ 
was significantly lower in the LK+-HNa+ group compared to the CON and NK+-HNa+ 
groups (both P<0.0001). The urinary Na+/K+ ratio was significantly higher in the LK+-
HNa+ compared to CON and NK+-HNa+ groups (both P< 0.0001). 
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Table 4.1 Effect of dietary sodium and potassium on urinary parameters in male 
Sprague Dawley rats. 
CON NK+- HNa+ LK+- HNa+ 
Urine volume(mL) 6.2 ± 0.8 6.3 ± 0.7 7.7 ± 0.7 
Urinary Na+ excretion 392 ± 9 1335 ± 17* # 1747±18 
(mmol/12h) 
Urinary K+ excretion 623 ± 18 465 ± 10 #\ 112 ± 1 
(mmol/12h) 
Na+/K+ 1.4 ± 0.7 3.8 ± 0.8 #1 16.1 ± 1.6 
Data expressed as means ± SEM, n=12 per group. *P < 0.01 NK+-HNa+ group 
# + + 1 + 
versus CON group, P < 0.01 LK -HNa group versus CON group, P < 0.01 LK -
HNa+ group versus NK+-HNa+ group. Na+/K+, urinary sodium to potassium ratio; CON, 
normal potassium-normal sodium diet; NK+-HNa+ , normal potassium-high sodium 
diet; LK+-HNa+, low potassium-high sodium diet. 
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4.3 The effect of a high sodium and low potassium diet on blood pressure 
Figure 4.2 shows the weekly measures of systolic (SBP) and diastolic (DBP) blood 
pressures during the dietary intervention, from baseline (week 0) until termination 
(week 6). The SBP and DBP for the CON group did not change during the 6 week 
dietary intervention compared to baseline (P>0.05). The LK+-HNa+ group displayed a 
significant increase in SBP on weeks 3 (135 mm Hg), 5 (136 mm Hg) and 6 (134 mm 
Hg) compared with week 0 (120 mm Hg) (P=0.01, P= 0.01and P=0.03 respectively). 
The increase in SBP was not different between NK+-HNa+ and LK+-HNa+ (P>0.05). 
Following the 6 weeks of dietary intervention, the SBP was significantly higher in the 
NK+-HNa+ and the LK+-HNa+ groups compared to the CON group (P=0.05 and 
P=0.04 respectively) (Figure 4.2A). 
The LK+-HNa+ group displayed a significant increase in DBP on weeks 3 (97 mm Hg), 
5 (96 mm Hg) and 6 (94 mm Hg) compared with week 0 (81 mm Hg) (P=0.001, P= 
0.003 and P= 0.009 respectively). The increase in DBP was not different between 
NK+-HNa+ and LK+-HNa+ (P>0.05). Following 6 weeks of dietary intervention, the 
DBP was significantly higher in the NK+-HNa+ and LK+-HNa+ groups compared to the 
CON group (P=0.05 and P=0.02, respectively) (Figure 4.2B). 
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Figure 4.2 Impact of dietary sodium and potassium on weekly systolic (A) and diastolic (8) 
blood pressures in male Sprague Dawley rats. Data expressed as means ± SEM, n=12 per 
group. *P < 0.05 NK+-HNa+ group versus CON group. fp < 0.05 LK+-HNa+ group versus CON 
# 
group. P < 0.01 changes over time in the LK +-HNa+ group versus week O. S8P, systolic 
blood pressure; D8P, diastolic blood pressure; CON, normal potassium-normal sodium diet; 
NK+-HNa+, normal potassium-high sodium diet; LK+-HNa+, low potassium-high sodium diet. 
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4.4 The effect of a high sodium and low potassium diet on renal function 
The effects of the dietary sodium and potassium intake on creatinine clearance and 
right kidney (RKW) weight at termination are shown in Table 4.1. After the 6 week 
dietary intervention, no significant differences in the creatinine clearance were 
onserved between the different groups (P > 0.05). The RKW was significantly heavier 
in the LK+-HNa+ group compared to the CON (P= 0.006) and the NK+-HNa+ (P= 
0.008) groups. No significant differences were noted in the RKW in the NK+-HNa+ 
group compared to the CON group (P> 0.05). 
ss 
Table 4.2 Effect of dietary sodium and potassium on renal function in male Sprague 
Dawley rats. 
Creatinine 
clearance (mllmin) 
RKW (g) 
CON 
0.46 ± 0.17 
1.7±0.1 
0.33± 0.08 
1.7 ± 0.04 
0.29± 0.03 
#t 
1.9 ± 0.1 
# 
Data expressed as means ± SEM, n=12 per group. P < 0.01 LK+-HNa+ group versus 
t 
CON group, P < 0.01 LK+-HNa+ group versus NK+-HNa+ group. RKW, right kidney 
weight; CON, normal potassium-normal sodium diet; NK+-HNa+ , normal potassium-
high sodium diet; LK+-HNa+, low potassium-high sodium diet. 
S6 
4.5 The effect of a high sodium and low potassium diet on heart weight, 
dimension and function 
The heart weight, heart dimensions and left ventricular function of the three groups at 
termination is shown in Table 4.3 Following 6 weeks of dietary intervention, there 
were no significant differences in any of the variables between the three groups (P > 
0.05). 
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Table 4.3 Effect of dietary sodium and potassium on heart weight, dimensions and 
function in male Sprague-Dawley rats. 
CON NK+-HNa+ LK+-HNa+ 
HW(g) 1.33 ± 0.03 1.50 ± 0.08 1.47 ± 0.04 
RVW (g) 0.27 ± 0.02 0.30 ± 0.01 0.31 ± 0.02 
LVW (g) 0.96 ± 0.02 1.10 ± 0.07 1.06 ± 0.03 
HW/BW X 100 0.24 ± 0.01 0.27 ± 0.01 0.26 ± 0.01 
RVW/BWx 100 0.05 ± 0.01 0.05 ± 0.01 0.06 ± 0.01 
LVW/BWx 100 0.17 ± 0.01 0.19 ± 0.01 0.19 ± 0.01 
LVEDD (mm) 7.23 ± 0.17 7.26 ± 0.33 7.24 ± 0.17 
LVESD (mm) 3.57 ± 0.15 3.83 ± 0.32 3.43 ± 0.19 
PWED (mm) 1.94 ± 0.05 2.13 ± 0.05 1.90 ± 0.09 
PWES (mm) 2.69 ± 0.06 2.88 ± 0.07 2.76 ± 0.08 
FS end (%) 50.75 ± 1.37 47.93 ± 2.13 52.91 ± 1.87 
FS mid (%) 31.72 ± 0.93 28.61 ± 1.01 32.30 ± 1.63 
HW, heart weight; RVW, right ventricular weight; LVW, left ventricular weight; 
LVEDD, left ventricular end diastolic diameter; LVESD, left ventricular end systolic 
diameters; PWED, posterior wall thickness in diastole; PWES, posterior wall 
thickness in systole; FSend , endocardial fractional shortening, and FSmid , midwall 
fractional shortening; CON, normal potassium-normal sodium diet; NK+-HNa+, normal 
potassium-high sodium diet; LK+-HNa+, low potassium-high sodium diet. 
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4.6 The effect of a high sodium and low potassium diet on vascular 
responses 
4.6.1 Dose-responses to phenylephrine and potassium chloride 
Concentration-response curves to phenylephrine (Phe) (Figure 4.3A and 8) and 
potassium chloride (KCI) (Figure 4.3C and D) were constructed in mesenteric (Figure 
4.3, left panel) and renal arteries (Figure 4.3, right panel), respectively. The Phe-
induced contractions were significantly shifted to the left in NK+-HNa+ group 
compared to CON group (P=0.02) in mesenteric arteries. No significant differences 
were observed in the Phe-induced contractions between NK+-HNa+ and LK+-HNa+ 
groups (P>0.05) in both mesenteric and renal arteries. 
The EC50 and Emax values derived from these curves are presented in table 4.4 The 
EC50 of Phe in mesenteric arteries in the NK+-HNa+ group was significantly lower 
compared to the CON group (P=0.02). The EC50 in the LK+-HNa+ group in 
mesenteric arteries showed a trend toward significance compared to the EC50 in the 
Con group (P=0.06). No significant differences in the concentration-response curves, 
EC50 and Emax of KCI were noted between the groups in both mesenteric and renal 
arteries (all, P >0.05). 
4.6.2 Relaxation responses to acetylcholine and sodium nitroprusside 
Concentration-response curves to sodium nitroprusside (SNP) (Figure 4.4 A and 8) 
and acetylcholine (ACh) (Figure 4.4 C and D) were constructed in mesenteric (Figure 
4.4, left panel) and renal arteries (Figure 4.4, right panel), respectively. The EC50 and 
Emax values derived from these curves are presented in table 4.5. No significant 
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differences in the concentration-response curves, EC50 and Emax of SNP and ACh 
were noted between the groups in both mesenteric and renal arteries (P>O.05). 
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Figure 4.3 Effect of dietary sodium and potassium on contractile responses to phenylephrine (A and 8) and potassium 
chloride KCI (C and D) in mesenteric (left panel) and renal arteries (right panel). Data expressed as means ± SEM, n=9 per 
group. *P< 0.05 NK+ -HNa+ versus CON group. Phe, Phenylephrine; KCI, Potassium chloride; CON, normal potassium-
normal sodium diet; NK+-HNa+, normal potassium-high sodium diet; LK+-HNa+, low potassium-high sodium diet. 61 
Table 4.4 Contraction responses to phenylephrine and potassium chloride in mesenteric and renal arteries after the 
dietary intervention in male Sprague-Dawley rats. 
Mesenteric arteries Renal arteries 
CON NK+-HNa+ LK+-HNa+ CON NK+-HNa+ LK+-HNa+ 
EC50{IJM) 3.2±0.79 0.9 ±0.59* 1.1± 0.26 1.88±0.63 0.94±0.34 1.88±0.10 
Phe 
Emax{mN) 28.99±1.53 29.61±3.22 29.82± 2.28 19.38±2.11 16.12±2.81 21.36±2.39 
EC50 (mM) 23±1.00 20±1.00 20±1.00 20±1.00 40±1.00 30±1.00 
KCI 
Emax{mN) 20.98±3.90 17.09±1.98 18.87 ± 1.59 18.75±1.99 16.28±3.77 17.20±4.35 
Data expressed as means ± SEM, n=9 per group. *P< 0.05 NK+-HNa+ versus CON group. Phe, Phenylephrine; KCI, Potassium 
chloride; EC5o, concentration that induces half the maximum contraction; Emax, maximum contraction response; EC50 expressed in 
IJmole for Phe and mmole for KCI and Emax expressed in mN. CON, normal potassium-normal sodium diet; NK+-HNa+, normal 
potassium-high sodium diet; LK+-HNa+, low potassium-high sodium diet. 
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Figure 4.4 Effect of dietary sodium and potassium on relaxation responses to sodium nitroprusside (A and 8) and 
acetylcholine (C and D) in mesenteric (left panel) and renal arteries (right panel). Data expressed as means ± SEM, n=9 per 
group. SNP, Sodium nitroprusside; ACh, Acetylcholine; Con, normal potassium-normal sodium diet; NK+-HNa+, normal 
potassium-high sodium diet; LK+-HNa+, low potassium-high sodium diet. 63 
Table 4.5 Relaxation responses to sodium and acetylcholine in mesenteric and renal arteries after the dietary 
intervention in male Sprague-Dawley rats. 
Mesenteric arteries Renal arteries 
CON NK+-HNa+ LK+-HNa+ CON NK+-HNa+ LK+-HNa+ 
ECso (!-1M) O.O8±O.O3 O.53±O.39 O.63±O.55 O.68±O.38 1.3±O.O68 O.25±O.OO7 
SNP 
Emax(mN) 25.40±5.85 39.67±6.65 42.46±7.22 43±4.35 49.77±6.22 49. 12±6.45 
ECso (!-1 M) O.15±O.071 O.07±O.022 O.090±O.033 O.03±O.01 O.02±O.OO O.02±O.01 
ACh 
Emax{mN) 19.01±5.57 45.57±11.27 46.36±11.51 40.48±8.52 30.91±7.34 29.05±5.93 
Data expressed as means ± SEM, n=9 per group. SNP, Sodium nitroprusside; A.Ch, Acetylcholine; Ecso, concentration that 
induces half the maximum contraction; Emax, maximum contraction response; ECso expressed in !-Imole and Emax expressed 
as % of Phe-induced contraction. CON, normal potassium-normal sodium diet; NK+-HNa+, normal potassium-high sodium 
diet; LK+-HNa+, low potassium-high sodium diet. 
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CHAPTER 5 
DISCUSSION 
65 
5.1 Introduction 
The present study examined the effects of a high Na+ and a low K+ intake on BP in 
four-month-old SD rats. The main findings of the current study are that following a 6 
week dietary period, high Na+ intake induces an increase in BP. In addition high Na+ 
intake induces greater phenylephrine-induced vascular contractility which may be 
responsible for the increase in BP. However a low K+ diet does not exercerbate the 
effects of the high Na+ intake. It may be important to note that a high Na+ intake 
concurrently with a low K+ intake causes an increase in kidney weight. 
5.2 Changes in water intake, food intake, body weight and tibia length 
during the dietary intervention period 
In the present study, an increase in water intake was observed once the diet was 
supplemented with Na+. As Na+ concentrations were increased every two weeks, rats 
were drinking more water than when fed a normal Na+ diet. This suggests that 
consumption of high Na+ intake provided a rapid stimulus of thirst. Indeed, it is well 
documented in various rat strains that the daily water intake is elevated proportionally 
as dietary Na+ intake is increased (Gamble et al., 1929; Sticker et al., 2003). In both 
human and animal studies, when the osmolality is increased as a result of increased 
Na+ intake, thirst is stimulated and water intake increases (Gilman, 1937; McKinley 
and Johnson, 2004; Ramsay and Thrasher, 1990; de Wardener et al., 2004). 
In the present study, once more when Na+ was introduced in the diet, rats ate less in 
the first week compared to the control group. The lower food consumption in the high 
Na+ intake groups may be explained by a lower palatability or the novelty of the diet 
(Sticker et al., 2003). Following the first week of the diet intervention, rats increased 
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their food intake and food intake was similar in the three groups at the end of the 6 
week dietary intervention. Despite the differences in food intake between the groups, 
body weights and tibia lengths were similar throughout the diet intervention for the 3 
different experimental groups. This suggests that either the lower food intake with the 
increase in Na+ in the first week was not sufficient to cause a decrease in the rat body 
weights or the loss in body weight due to a lower food intake may have been 
compensated for by the increased water intake. Therefore the results of the present 
study imply that a high Na+ intake increased water intake without affecting body 
growth. 
5.3 Changes in urinary parameters after the dietary intervention period 
Animal studies have shown that a high Na+ intake increases urinary water 
concentration due to increased water intake (Denton et al., 1985; He et al., 2001). 
Indeed a high Na+ intake stimulates thirst, increases fluid intake, in order to reduce 
plasma osmolality and hence increases urinary volume (Shore et al., 1988). Although 
the literature provides evidence that high Na+ increases urinary water excretion, the 
present study did not show any differences in the urinary volume between the three 
groups. Similar to the present study, previous studies have showed unaltered urine 
volume in DSS rats receiving a high Na+ intake (Kurokawa et al., 2015; Simchon et 
al., 1989; Spinelli et al., 1987). One possible reason for the unaltered urine volume 
could be due to an increase in ADH secretion. Since extracellular Na+ concentration 
is a determinant of osmolality, variations in Na+ intake would be expected to influence 
ADH secretion. The high Na+ intake could have stimulated ADH secretion which 
caused water reabsorption in the distal tubule and collecting duct and consequentially 
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reduced water loss in urine (Cowley ef al., 1983; Kjeldsen ef al., 1985; Spinelli ef al., 
1987). Another possible reason for the unaltered urine volume despite increased 
water intake is that the rats were placed in metabolic cages and fasted overnight in 
order to collect urine. It is possible that the rats did not drink as much water during 
these 12 hours as usual since they were deprived of food. This may have altered 
urine excretion volume during the collection period. Alternatively the metabolic cages 
expose rats to stress which could have interfered with the total urine volume collected 
as has been seen in previous studies (Gil ef al., 1999; Stechman ef al., 2010; Vadjei 
ef al., 1990). 
Urinary Na+ excretion can provide a good estimate of Na+ intake since 95% of 
ingested Na+ is excreted in urine (Schachter ef al., 1980). Indeed in the present study 
urinary Na+ excretion increased in the high Na+ intake groups, reflecting the increased 
Na+ in the diet. In addition, urinary K+ excretion may also provide a good estimate of 
K+ intake (Tasevska ef al., 2006). In the present study, a low K+ diet in conjunction 
with a high Na+ diet for 6 weeks resulted in a marked decrease in urinary K+ excretion 
and increased the Na+/K+ compared to the other groups, confirming the greater Na+ 
intake in conjunction with the lower K+ intake. The present study is in agreement with 
previous studies showing an increased Na+/K+ due to a low K+ intake (Du ef al., 2014; 
Coruzzi ef al., 2001; Krishna ef aI., 1989; Morris ef al., 1999; Zhang ef al., 2013). 
5.4 Changes in blood pressure during the dietary intervention period 
In the present study, the consumption of a high Na+ diet for 6 weeks resulted in a 
significant increase in SBP and DBP compared to the rats receiving the control diet. 
An increase in SBP and DBP was observed on the third week when rats were 
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receiving a 4% Na+ diet and on the fifth and sixth week when rats were receiving a 
6% Na+ diet. 
Indeed many clinical studies suggest that a high Na+ can increase BP in both 
hypertensive and normotensive individuals (Draaijer et al., 1995; Elliot et al., 1996; 
Gerdts et al., 1994; Hedayati et al., 2012; Hu and Tian, 2001; Huggins et al., 2011; 
Meneton et al., 2005; Polonia et al., 2006; Rodrigues et al., 2015; Sharma et al., 
1989; Weinberger, 1996; Zhang et al., 2013). In addition, high Na+ intake is known to 
result in increases in BP in various rat strains especially in genetically selected DSS 
rats (Adegunloye and Sofola, 1996; Dahl et al., 1962; Giardina et al., 2001; Gu et al., 
2008; Huang and Johns, 2000; Sofala et al., 2002; Walkowska et al., 2015; Wu et al., 
1995; Wu et al., 2000). However the effect of high Na+ intake on BP has been studied 
to a lesser extent in normotensive rats such as SD rats. In the present study, no 
significant increase in SBP and DBP was observed on the first and second week 
when rats were receiving a 2% Na + diet. These results are consistent with previous 
findings in male SD rats showing no changes in BP after two weeks, despite being on 
an 8% Na+ diet (Debinski et al., 1990; Farjah et al., 2004; Jernigan et al., 2007; Gu et 
al., 2008; Mattson and Higgins, 1996; Titze et al., 2006). Therefore the results of the 
present study may imply that a short-term high Na+ intake is insufficient to cause 
changes in BP and that a longer duration intervention may be needed. 
In this regard we have demonstrated that on a 4% Na+ diet from week 3 to 4 and a 
6% Na+ diet from week 5 to 6, SBP and DBP significantly increased compared to the 
control group. These findings suggest that 4% and 6% Na+ intake can induce 
increases in BP in normotensive rats. Although there was an increase in BP in the 
high Na+ groups SBP increases did not exceed 140 mm Hg, and hence the rats did 
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not develop hypertension. Indeed Gu et al (2008) reported that an 8% Na+ intake for 
8 weeks causes hypertension in SO rats. Hence a greater Na+ intake with a longer 
diet intervention may have caused hypertension in the normotensive rats. 
Moreover, as highlighted in chapter 2 the relationship between a high Na+ and low K+ 
intake with BP has been found to be stronger than Na+ alone. In the present study, 
consumption of a low K+ diet did not exacerbate the high Na+-induced increases in 
BP. These results are in contrast to previous human and animal studies. Krishna and 
colleagues (1989) investigated the effects of dietary K+ on BP using either low (10 
mmol/day) or normal (90 mmol/day) amounts of K+ in conjunction with a high Na+ 
intake (120-200 mmol/day) in normotensive men. They reported no change in BP 
during normal K+ intake, but increased BP (4.1 mm Hg) with low K+ intake (Krishna et 
al., 1989). The same participants were given a saline infusion which further increased 
BP in those on the low K+ diet but had no effect on those consuming the normal K+ 
diet (Krishna et al., 1989). Similarly, Coruzzi and colleagues (2001) showed that there 
was a reduction in urinary K+ excretion which was associated with increased SBP in 
patients receiving high Na+ intake (200 mmol/day) and a low K+ (18 mmol/day) diet. 
Morris et al (1999) reported that when dietary K+ intake was reduced, dietary Na+ 
loading induced a significant increase in BP. 
Moreover the evidence of the effect a high Na+ and low K+ intake on BP has been 
reported in animal studies. In weanling hypertensive rat strains, studies have reported 
that a low K+ intake exacerbates Na+-induced increase in BP (Dietz et al., 1984; Wu 
et al., 1995; Wu et al., 1996; Wu et al., 2000). Interestingly, the high Na+ and low K+ 
diet induced SS-HTN only after 4 weeks on a high Na+ (8%) diet (Dietz et al., 1984; 
Wu et al., 1995; Wu et al., 1996; Wu et al., 2000). Similar to the effects observed in 
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the weanling hypertensive rat strains (Dietz et al., 1984; Wu et al., 1995; Wu et aI., 
1996; Wu et al., 2000), a low K+ diet with a high Na+ intake induced SS-HTN in 
weanling normotensive rat strains only after 4 weeks on the dietary intervention (Ray 
et al., 2001). Ray et al (2001) reported that a low K+ diet with a high Na+ intake 
resulted in a more marked increase in BP compared to rats only receiving a high Na+ 
diet. Weanling SD rats receiving a normal Na+ diet (0.3%) combined with a low K+ « 
0.05%) diet for 3 weeks had higher SBPs (114± 7.4 mm Hg) than the rats a normal 
Na+ combined with a normal K+ diet (91 ± 5.3 mm Hg) (Ray et al., 2001). In order to 
determine whether the increase in BP was associated with salt-sensitivity, rats were 
switched to a high Na+ (6% Na+) diet for 1 week (Ray et al., 2001). The high Na+ diet 
resulted in marked increases in SBP (155 ± 14 mm Hg) in the rats receiving a low K+ 
diet compared to the receiving a normal K+ diet (123 ± 8.9 mm Hg) (Ray et al., 2001). 
The study concluded that dietary K+ deficiency increases BP and induces salt-
sensitivity in weanling normotensive rats (Ray et al., 2001 ).However, in the present 
study, when a high Na+ diet was combined with a low K+ diet no significant changes 
in BP were observed compared to the rats receiving a normal K+ diet in conjunction 
with a high Na+ intake. It is possible that a low dietary K+ intake could have a greater 
effect in younger than older rats as it has been reported that young rats are more 
sensitive to changes in dietary K+ and Na+ than adult rats (Ray et al., 2001; Wu et al., 
1995). 
Moreover Dahl et al (1972) showed that when weanling rats receive a high Na+ and 
low K+ diet long-term (12 months) significant BP changes occurred. In the prior study 
Dahl et al., 1972 showed that the lower the K+ intake in conjunction with a constant 
high Na+ intake, the higher the BP after the 12 months dietary intervention (Dahl et 
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al., 1972). Therefore the 6 week dietary intervention period in the present study may 
have been too short for a low K+ diet to worsen the high Na+-induced increases in BP. 
5.5 Changes in renal function after the dietary intervention period 
In the present study neither high dietary Na+ alone or in combination with low dietary 
K+ had any effect on normal renal function as indicated by creatinine clearance. This 
is in contrast with other studies that have shown profound effects of a high Na+ and a 
low K+ diet on renal function. These changes include a reduction in creatinine 
clearance accompanied by a decline in the number of functioning nephrons 
(Muntwyler and Griffin, 1953; Ray ef al., 2001; Suga ef al., 2002;Yachantha ef al., 
2009; Wu ef al., 2000). Suga et al (2002) reported reduced creatinine clearance in 3 
month old SO rats receiving a low K+ (0.01 %) diet for 10 weeks. Hence the 
discrepancies may be due to the shorter duration of the present study. 
In the present study, the consumption of a high Na+ diet did not alter the weights of 
the right kidneys. However the right kidney weight was significantly heavier in the rats 
receiving a high Na+ and a low K+ diet. The present finding is consistent with 
previous studies where others have shown that a high Na+ intake concurrently with a 
low K+ intake causes enlargement of the kidneys and striking changes in their tubular 
structure leading to kidney failure (Brokaw, 1953; Elger ef al., 1992; Ray ef al., 2001; 
Suga ef al., 2001; Wu ef al., 2000). However, the precise mechanism by which low K+ 
intake increases kidney weight was not elucidated. One possibility is that there was 
an increase in extracellular volume in the kidneys and hence increasing the kidney 
weight. However, more studies are needed to determine pathogenic mechanisms of 
the increased kidney weight due to high Na+ and low K+ intake. 
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5.6 Changes in cardiac function after the dietary intervention period 
In order to determine the effect of increased BP in response to high Na+ intake, heart 
dimensions and function were measured. In the present study the consumption of a 
high Na + diet resulted in no significant changes in the hearts dimensions and function 
compared to the control diet. These results are in contrast with previous studies. 
Previous studies have reported that a high Na+ (8%) diet for 8 weeks results in left 
ventricular hypertrophy in normotensive weanling Wistar rats (Yu et a/., 1998; Lal et 
a/., 2003). Moreover, Cordaillat et a/ (2010) investigated the effects of a high Na+ 
(8%) diet on cardiac structure and function in weanling SD rats for 5 months. They 
reported that the high Na + intake for 5 months resulted in left ventricular hypertrophy 
without changes of systolic and diastolic function (Cordaillat et a/., 2010). Therefore 
the results of the present study may imply that a 6 week high Na+ dietary intervention 
may have been too short to cause structural changes to the heart. 
Moreover human studies have suggested that a high Na+ to K+ ratio is more strongly 
associated with left ventricular hypertrophy than Na+ intake alone (Cook et a/., 2009; 
Daniels et a/., 1990; du Cailar et a/., 1992; du Cailar et a/., 2002; Rodriguez et a/., 
2011; Tuomilehto et al., 2001; Schmieder and Messerli, 1988). Yet in the present 
study, no high Na + or low K+ -induced increases of the left ventricular wall were 
demonstrated after the 6 week dietary intervention period. It is possible that the 
duration of the present study was not extensive enough to cause changes in the 
hearts structure and function. Despite increases in BP after the increased Na+ intake, 
the rats were not hypertensive; hence it is unlikely that the rats would have developed 
hypertension induced left ventricular hypertrophy or changes in cardiac function. 
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Nevertheless there was also no direct effect of the high Na+ on the cardiac structure 
or function. Hence more studies with a longer duration dietary intervention where the 
rats do develop hypertension are needed to determine whether high Na + and low K+ 
intake directly or indirectly may cause cardiac changes. 
5.7 Vascular reactivity 
5.7.1 Vasoconstrictor responses in mesenteric and renal arteries after the 
dietary intervention period 
In the present study, the consumption of a Na+ diet increased the vascular 
responsiveness to phenylephrine in mesenteric arteries. This is in agreement with 
previous studies that have reported enhanced phenylephrine contractility in isolated 
aortic rings (Adegunloye and Sofola, 1997; Obiefuna et al., 1991) and perfused 
mesenteric beds (dos Santos et aI., 2005; Sofola et al., 2002). The increased 
vascular reactivity to phenylephrine may be explained in part by an increase in the 
sensitivity to phenylephrine at the a-receptor level (Smith et al., 2003). 
In addition, no changes in phenylephrine-induced contractions were observed in the 
renal arteries suggesting that enhanced phenylephrine-induced contractions by high 
Na+ intake is not generalized to all vascular beds. Since mesenteric arteries are 
resistance arteries, they contribute substantially more to changes in TPR than renal 
arteries. Hence the short-term effect of high Na + intake may be primarily on 
resistance arteries. Indeed, Yu and colleagues demonstrated no changes in renal 
vascular function after 4 weeks of high Na+ intake (Yu et aI., 1998). However 
increased renal media wall to lumen ratio and fibrosis were reported in this study 
which could have led to the increase in BP. In this regard structural changes in the 
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blood vessel walls could represent an adaptive phenomenon in which the blood 
vessel wall thickens in response to an increase in BP (Simon et al., 2001; Tanoue et 
al., 2002). Therefore further studies are needed to assess the effect of high Na+ 
intake on vascular structural changes in both renal and mesenteric arteries. 
In the present study, a low K+ did not affect phenylephrine-induced contractions as 
the contractions were similar between the rats receiving a normal and a low K+ diet. 
To my knowledge, this is the first study to report on the effects of a low K+ on vascular 
responsiveness. Previous studies have only assessed the effects of high K+ intake on 
vascular responsiveness (Amberg et al., 2003; Dietz et aI., 1984; Edwards and 
Weston, 2004; Haddy et al., 2006; Houston et al., 2011; Raij et al., 1988; Sudhir et 
al., 1993). Dietz et al (1984) reported that the sensitivity of VSM to noradrenaline is 
enhanced in weanling hypertensive SHRs on a high Na+ diet. However these 
changes in noradrenaline are reversed when the concentration of K+ in a high Na+ 
diet is increased. Therefore these results show that K+ supplementation reduces VSM 
vasoconstriction in the hypertensive rat strain (Dietz et al., 1984). However in 
normotensive WKY rats no K+ supplementation effect was observed (Dietz et al., 
1984). Therefore maybe a low K+ diet could be more sensitive in hypertensive rat 
strains as compared to normotensive rat strains. 
Furthermore the present study determined whether high Na+ intake and a low K+ was 
associated with changes in the vascular reactivity to KCI. KCI causes membrane 
depolarization and stimulates Ca2+ entry through voltage gated Ca2+ channels (Khalil 
and van Breemen, 1995). In the present study, no differences in reactivity to KCI were 
observed between any of the groups, either in mesenteric or renal arteries. 
Conversely, Smith et al (2003) reported that high Na+ (8%) causes increased KCI 
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contractions in aortic rings of 3 month old SO rats after 9 days on the diet. However in 
the present study high Na+ did not cause increased membrane depolarization. This 
could be due to the lower Na+ concentration (6%) in the diet. Therefore, in the present 
study, it is more likely that high Na + intake leads to increased BP by increasing 
contraction-induced by o1-adrenoceptor agonists rather than increasing membrane 
depolarization in mesenteric arteries. 
5.7.2 Vasodilator responses in mesenteric and renal arteries after the dietary 
intervention period 
In the present study, the ACh-induced vasodilation in both renal and mesenteric 
arteries was similar in the different experimental groups. Impaired endothelium-
dependent relaxation has been reported in mesenteric arteries (Sofola et al., 2002) 
and the aorta (Adegunloye and Sofola, 1997) of rat models of SS-HTN in response to 
ACh. Studies have reported that a high Na+ intake in normotensive rats causes 
impaired endothelium-dependent arteriolar responses to ACh and most probably 
because of the suppression of local NO activity (DuPont et al., 2013; Kagota et al., 
2001; Lenda et al., 2000). Indeed, high Na+ diet for 6 weeks caused a 40% reduction 
of renal vasodilator effects of ACh (Fiore et aI., 2011). Moreover studies have 
suggested that high Na+ and high K+ levels have complementary effects to reduce 
availability of NO leading to VSM contraction (Raij et al., 1988; Zhou et al., 2000). 
However, the effect of a low K+ diet in conjunction with a high Na+ is unknown. The 
present study indicate that the endothelial capacity to release endothelial derived 
relaxing factor (EDRF) is not modified in mesenteric and renal arteries after 6 weeks 
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of a high Na+ intake. Moreover the combination of high Na+ and low K+ intake did not 
impair endothelium-dependent vasodilation in both mesenteric and renal arteries. 
Previous studies have only assessed the effect of K+ supplementation in conjunction 
with a high Na+ diet (Raij et a/., 1988; Zhou et a/., 2000). Zhou et 8/ (2000) and Raij et 
a/ (1988) reported that K+ supplementation improves endothelium-depend NO-
mediated relaxation in response to ACh in DSS rats. It is noteworthy that these were 
weanling hypertensive DSS rat, therefore maybe the effects of K+ is more sensitive in 
weanling hypertensive rat strains rather than normotensive rat strains. 
Furthermore the present study determined whether high Na+ intake was associated 
with changes in the vascular reactivity to SNP. SNP spontaneously generates NO via 
an endothelium-independent manner (Kagota et a/., 2001). In this study, the 
responsiveness of mesenteric and renal arteries to SNP was not different between 
the groups. This study is in agreement with previous reports showing the inability of 
high Na+ intake in changing vascular responsiveness to SNP (80egehold, 1993; 
Frisbee and Lombard, 1998; Lenda et a/., 2000). These observations suggests that 
the ability of VSM to respond to the NO donor and hence the guanylate cyclase 
enzyme which mediates the action of SNP is not altered by high Na+ intake. Moreover 
a low K+ diet did not alter the responsiveness of mesenteric and renal arteries to 
SNP. Therefore additional experiments are necessary to identify the endothelial 
factors that might be altered after high Na + and low K+ intake. 
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CHAPTER 6 
CONCLUSIONS 
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6.1 Conclusions 
The present study investigated the effects of a 6-week high dietary Na+ and low 
dietary K+ intake on BP in four-month-old male SD rats. The present study shows that 
6 weeks of high Na+ intake increases BP and increases vascular responsiveness to 
phenylephrine in mesenteric arteries. These findings suggest that the greater 
phenylephrine-induced mesenteric vascular contractility could be responsible for the 
increase in BP. Nevertheless the rats did not develop hypertension as animals 
remained normotensive after the 6-weeks dietary intervention. In addition, a 6 week 
high Na+ intake does not affect heart dimensions and function. This suggests that a 6 
week high Na+ intake does not cause cardiac changes associated with the increase in 
BP, possibly because the rats did not become hypertensive. The data presented is 
novel in showing that a low K+ intake has little effect on Na+-induced increases in BP 
however it can cause an increase in kidney weight. Although the present study has 
not shown the mechanisms involved in the increase in kidney weight, it serves as a 
platform for future studies. 
6.2 Limitations and future studies 
The possible limitations to this study are as follows; first, the present study focused 
on the short-term effect of a high Na+ and low K+ intake on BP. Although the 
intervention did result in significant BP changes in the normotensive rats, the rats did 
not develop hypertension and hence the duration may have been too short. Future 
studies should investigate the long-term effect of the diet as it may result in more 
adverse outcomes. 
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Second, due to the high cost of the K+ dificient diet (R50 000 for 20Kg) only three 
dietary groups could be investigated. Hence future studies should also investigated 
the effects of a low K+ with normal Na+ diet on BP. Third, SBP and DBP were 
measured using the non-invasive tail cuff technique. The main limitation of this 
method is that measurements can only be performed in restrained rats which could 
have induced stress to the animals and hence affected BP. However the stress was 
minimized by habituating the rats to the restrainers and the BP machine for two 
weeks before data collection commenced. Future studies should use the telemetry 
technique which is more reliable and is used to determine the accuracy of non-
invasive blood pressure measurements by implanting radio transmitters at the carotid 
artery of the rats at the beginning of the experiment. Thourth, no histology was 
performed to see whether the low K+ resulted in any histological changes in the 
kidney due to the increase in kidney size. Hence future studies need to assess the 
histological changes to the kidney. Fourth, mesenteric and renal arteries were 
mounted on two steel wires for isometric force measurements (wire-myograph) which 
is not the most physiological technique as part of the endothelial surface is under 
pressure exerted by the wires which could possibly damage the vessels. Future 
studies should use the pressure perfused vessel technique which develops myogenic 
tone and is more physiological and sensitive than the wire-myograph. Moreover, only 
the functional changes in mesenteric and renal arteries were assessed. Future 
studies should look at the structural changes in these blood vessel walls as structural 
changes could cause arterial wall thickness in response to an increased BP. Finally, 
as urinary Na+ and K+ concentrations were measured, future studies should measure 
plasma Na+ and K+ concentrations to compare the findings. 
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6.3 Possible clinical implications and recommendations 
By confirming that high Na+ intake increases BP and causes pathological changes in 
the vasculature, it remains of paramount importance to reinforce a low Na+ diet as a 
strategy for the prevention and treatment of SS-HTN. In addition the importance of 
maintaining adequate K+ intake needs further investigations. Although low K+ intake 
only had little effect on Na + induced increases in BP, low K+ could cause detrimental 
effects on the kidney. Hence further studies are needed to assess the effects of 
dietary K+ on target organ changes. In addition a better understanding of the 
mechanisms involved in the regulation of BP by Na+ and K+ is needed. This will 
provide important insights into understanding salt sensitivity and hence guide dietary 
strategies to prevent SS-HTN. 
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